##analysisDate=2017-05-10-14-11-27000																																															
##analyzedBy=RingStudy Site F																																															
##exportDate=2017-11-08-10-56-10000																																															
##analysisName=Site F-EGFR_DNA_Ref-C																																															
##workflowName=Oncomine Comprehensive v3 - w2.1 - DNA - Single Sample																																															
##sampleNames=Site F-EGFR_DNA_Ref-C_v1																																															
##reference=hg19																																															
##variantGroup=DEFAULT																																															
##filterChain=Site D_NoRef																																															
##searchText=																																															
##chromosome=All																																															
##totalVariantCount=1699																																															
##filterInCount=146																																															
##filteredOutCount=1553																																															
##hiddenVariantCount=0																																															
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	Allele Coverage	p-value	Phred QUAL Score	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:11184586	T/C	T	SNV		MTOR	exonic	1								6.2	p.Asn2211Asp		2000	"T=0.938, C=0.062"		-	47	NM_004958.3	c.6631A>G	missense	2.23	0.13	23	0.005	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"								"ATP binding,Golgi apparatus,Golgi membrane,PML body,RNA polymerase III type 1 promoter DNA binding,RNA polymerase III type 2 promoter DNA binding,RNA polymerase III type 3 promoter DNA binding,T cell costimulation,TFIIIC-class transcription factor binding,TOR signaling cascade,TORC1 complex,TORC2 complex,cell growth,cellular response to hypoxia,cellular response to nutrient levels,cytoplasm,cytosol,dendrite,endomembrane system,endoplasmic reticulum,endoplasmic reticulum membrane,fibroblast growth factor receptor signaling pathway,germ cell development,growth,insulin receptor signaling pathway,kinase activity,lysosome,mTOR-FKBP12-rapamycin complex,membrane,mitochondrial outer membrane,mitochondrion,negative regulation of NFAT protein import into nucleus,negative regulation of autophagy,negative regulation of cell size,negative regulation of macroautophagy,nerve growth factor receptor signaling pathway,neuronal cell body,nucleotide binding,nucleus,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,phosphatidylinositol 3-kinase complex,phosphatidylinositol-mediated signaling,phosphoprotein binding,phosphorylation,phosphotransferase activity, alcohol group as acceptor,positive regulation of actin filament polymerization,positive regulation of endothelial cell proliferation,positive regulation of lamellipodium assembly,positive regulation of lipid biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling cascade,positive regulation of protein phosphorylation,positive regulation of stress fiber assembly,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,protein autophosphorylation,protein binding,protein catabolic process,protein domain specific binding,protein phosphorylation,protein serine/threonine kinase activity,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of carbohydrate metabolic process,regulation of carbohydrate utilization,regulation of fatty acid beta-oxidation,regulation of glycogen biosynthetic process,regulation of protein kinase activity,regulation of response to food,response to amino acid stimulus,response to insulin stimulus,response to nutrient,ribosome binding,ruffle organization,signal transduction,soluble fraction"	"Everolimus,Pimecrolimus,Sirolimus,Temsirolimus"		"T=1876, C=124"	0.00001	134.737		"T=1084/792, C=70/54"	2	
chr1:27101281	C/T	C	SNV		ARID1A	exonic	1								51.55	p.(=)		1577	"C=0.4845, T=0.5155"		+	18	NM_006015.4	c.4563C>T	synonymous	-1.44				ARID/BRIGHT DNA binding domain	rs149095176			0	0.0016	5.00E-04		"DNA binding,SWI/SNF complex,androgen receptor signaling pathway,chromatin remodeling,chromatin-mediated maintenance of transcription,glucocorticoid receptor signaling pathway,intracellular,intracellular estrogen receptor signaling pathway,ligand-dependent nuclear receptor binding,nBAF complex,nervous system development,npBAF complex,nuclear chromatin,nucleolus,nucleosome disassembly,nucleosome mobilization,nucleus,positive regulation of transcription, DNA-dependent,protein binding,regulation of transcription from RNA polymerase II promoter,transcription coactivator activity"			"C=764, T=813"	0.00001	7759.41		"C=387/377, T=420/393"	4	
chr1:40363054	C/C	G	SNV		MYCL	exonic	1								100	p.Thr392Ser		582	"G=0.0, C=1.0"		-	3	NM_001033082.2	c.1175C>G	missense	1.32	1	58	0	"Helix-loop-helix DNA-binding domain,Myc amino-terminal region"	rs3134614		0.055 (ref)	0.1328	0.0252	0.0963	YES	"DNA binding,nucleus,regulation of transcription, DNA-dependent,sequence-specific DNA binding transcription factor activity"			"G=0, C=582"	0.00001	8799.45		"G=0/0, C=298/284"	1	
chr1:65310489	T/C	T	SNV		JAK1	exonic	1								51.38	p.(=)		1993	"T=0.4862, C=0.5138"		-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				"Protein kinase domain,Protein tyrosine kinase"	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	"ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway"	"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile"		"T=969, C=1024"	0.00001	9785.81		"T=444/525, C=504/520"	1	
chr1:156843543	T/C	T	SNV		NTRK1	exonic	1								46.52	p.(=)		1410	"T=0.5348, C=0.4652"		+	8	NM_002529.3	c.969T>C	synonymous	-1.9				"Protein kinase domain,Protein tyrosine kinase"								"ATP binding,Ras protein signal transduction,activation of MAPKK activity,activation of adenylate cyclase activity,activation of phospholipase C activity,axonogenesis involved in innervation,cell differentiation,developmental programmed cell death,endosome,integral to plasma membrane,multicellular organismal development,negative regulation of cell proliferation,negative regulation of neuron apoptosis,nerve growth factor binding,nerve growth factor receptor activity,nerve growth factor receptor signaling pathway,nervous system development,neurotrophin binding,nucleotide binding,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of NF-kappaB transcription factor activity,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of angiogenesis,positive regulation of neuron projection development,positive regulation of programmed cell death,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,receptor activity,small GTPase mediated signal transduction,sympathetic nervous system development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"	"Amitriptyline,Imatinib"		"T=754, C=656"	0.00001	5868.75		"T=431/323, C=377/279"	1	
chr1:156846233	G/A	G	SNV		NTRK1	exonic	1								45.73	p.(=)		831	"G=0.5427, A=0.4573"		+	14	NM_002529.3	c.1674G>A	synonymous	0.77				"Protein kinase domain,Protein tyrosine kinase"	rs6334		0.213 (ref)	0.2194	0.1432	0.1936	YES	"ATP binding,Ras protein signal transduction,activation of MAPKK activity,activation of adenylate cyclase activity,activation of phospholipase C activity,axonogenesis involved in innervation,cell differentiation,developmental programmed cell death,endosome,integral to plasma membrane,multicellular organismal development,negative regulation of cell proliferation,negative regulation of neuron apoptosis,nerve growth factor binding,nerve growth factor receptor activity,nerve growth factor receptor signaling pathway,nervous system development,neurotrophin binding,nucleotide binding,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of NF-kappaB transcription factor activity,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of angiogenesis,positive regulation of neuron projection development,positive regulation of programmed cell death,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,receptor activity,small GTPase mediated signal transduction,sympathetic nervous system development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"	"Amitriptyline,Imatinib"		"G=451, A=380"	0.00001	3369.21		"G=259/192, A=165/215"	1	
chr1:243828126	G/T	G	SNV		AKT3	exonic	1	Hotspot	Gain-of-function			HS	COSM242892		5.74	p.Gln78Lys		732	"G=0.9426, T=0.0574"		-	3	NM_005465.4	c.232C>A	missense	2.89	0	53	0.986	"PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,Golgi apparatus,cytoplasm,mitochondrial genome maintenance,nucleolus,nucleotide binding,nucleus,plasma membrane,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,signal transduction"			"G=690, T=42"	0.00076	31.1815		"G=336/354, T=25/17"	2	
chr2:29420501	T/C	T	SNV		ALK	exonic	1								49.4	p.Tyr1327Cys		2000	"T=0.506, C=0.494"		-	27	NM_004304.4	c.3980A>G	missense	1.02	0	194	1	"MAM domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"T=1012, C=988"	0.00001	9218.45		"T=506/506, C=509/479"	1	
chr2:178098917	C/T	C	SNV		NFE2L2	exonic	1								44.56	p.Arg43Gln		1378	"C=0.5544, T=0.4456"		-	2	NM_006164.4	c.128G>A	missense	0	1	43	0	"Basic region leucine zipper,bZIP transcription factor"	rs35248500		0.006 (ref)	1.00E-04	0.0139	0.0044		"cellular response to oxidative stress,centrosome,chromatin,cytoplasm,cytosol,endoplasmic reticulum unfolded protein response,nucleus,plasma membrane,positive regulation of blood coagulation,positive regulation of reactive oxygen species metabolic process,positive regulation of transcription from RNA polymerase II promoter,protein dimerization activity,protein domain specific binding,regulation of embryonic development,regulation of removal of superoxide radicals,regulation of transcription, DNA-dependent,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,transcription from RNA polymerase II promoter"			"C=764, T=614"	0.00001	5357.3		"C=352/412, T=298/316"	2	
chr2:209113192	G/A	G	SNV		IDH1	exonic	1								48.8	p.(=)		2000	"G=0.512, A=0.488"		-	4	NM_005896.3	c.315C>T	synonymous	1.35				Isocitrate/isopropylmalate dehydrogenase	rs11554137		0.049 (ref)	0.0531	0.106	0.071	YES	"2-oxoglutarate metabolic process,NAD binding,NADPH regeneration,carbohydrate metabolic process,cellular lipid metabolic process,cytoplasm,cytosol,glutathione metabolic process,glyoxylate cycle,isocitrate dehydrogenase (NADP+) activity,isocitrate metabolic process,magnesium ion binding,mitochondrion,oxidoreductase activity,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,peroxisomal matrix,peroxisome,protein homodimerization activity,response to oxidative stress,tricarboxylic acid cycle"	"2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitric Acid"		"G=1024, A=976"	0.00001	9038.78		"G=571/453, A=527/449"	1	
chr3:10108991	G/A	G	SNV		FANCD2	exonic	1								46.08	p.(=)		1992	"G=0.5392, A=0.4608"		+	26	NM_033084.3	c.2484G>A	synonymous	0.29					rs55980657		0.007 (ref)	1.00E-04	0.022	0.0075		"DNA repair,cell cycle,condensed chromosome,gamete generation,nucleoplasm,nucleus,protein binding,response to gamma radiation,synapsis"			"G=1074, A=918"	0.00001	8174.12		"G=529/545, A=416/502"	1	
chr3:37061883	C/A	C	SNV		MLH1	exonic	1								48.83	p.Leu323Met		1239	"C=0.5117, A=0.4883"		+	11	NM_000249.3	c.967C>A	missense	0.75	0	15	0.542	"DNA mismatch repair protein,Histidine kinase-"								"ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,MutLalpha complex,MutLbeta complex,MutSalpha complex binding,cell cycle,cellular response to organic cyclic compound,chiasma,double-strand break repair via nonhomologous end joining,guanine/thymine mispair binding,isotype switching,male germ cell nucleus,male meiosis chromosome segregation,meiotic metaphase I plate congression,mismatch repair,mismatched DNA binding,negative regulation of mitotic recombination,nuclear-transcribed mRNA poly(A) tail shortening,nucleus,oogenesis,pachytene,protein binding,reciprocal meiotic recombination,resolution of meiotic recombination intermediates,response to drug,response to hypoxia,response to toxin,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,spermatogenesis,spindle midzone assembly involved in meiosis,synaptonemal complex"			"C=634, A=605"	0.00001	5575.88		"C=361/273, A=357/248"	2	
chr3:47125385	A/A	G	SNV		SETD2	exonic	1								100	p.Pro1962Leu		1994	"G=0.0, A=1.0"		-	12	NM_014159.6	c.5885C>T	missense	0.33	0.06	98	0	"SET domain,WW domain"	rs4082155		0.496 (ref)	0.4338	0.2862	0.4713	YES	"DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding"			"G=0, A=1994"	0.00001	30316.3		"G=0/0, A=1011/983"	3	
chr3:47162661	G/G	A	SNV		SETD2	exonic	1								100	p.(=)		1986	"A=0.0, G=1.0"		-	3	NM_014159.6	c.3465T>C	synonymous	-0.59				"SET domain,WW domain"	rs6767907		0.316 (ref)	0.4088	0.2506	0.3552	YES	"DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding"			"A=0, G=1986"	0.00001	30261.8		"A=0/0, G=1005/981"	1	
chr3:52437223	C/T	C	SNV		BAP1	exonic	1								49.15	p.(=)		1998	"C=0.5085, T=0.4915"		-	14	NM_004656.3	c.1821G>A	synonymous	-1.48				Ubiquitin carboxyl-terminal hydrolase								"PR-DUB complex,chromatin binding,chromatin modification,cysteine-type peptidase activity,cytoplasm,intracellular,intracellular membrane-bounded organelle,monoubiquitinated histone H2A deubiquitination,negative regulation of cell proliferation,nucleolus,nucleus,peptidase activity,protein K48-linked deubiquitination,protein binding,protein deubiquitination,protein modification process,proteolysis,regulation of cell cycle,regulation of cell growth,ubiquitin thiolesterase activity,ubiquitin-dependent protein catabolic process,ubiquitin-specific protease activity"			"C=1016, T=982"	0.00001	9134.06		"C=514/502, T=468/514"	2	
chr3:52437597	G/T	G	SNV		BAP1	exonic	1								52.17	p.Pro522Thr		1501	"G=0.4783, T=0.5217"		-	13	NM_004656.3	c.1564C>A	missense	2.88	0	38	1	Ubiquitin carboxyl-terminal hydrolase								"PR-DUB complex,chromatin binding,chromatin modification,cysteine-type peptidase activity,cytoplasm,intracellular,intracellular membrane-bounded organelle,monoubiquitinated histone H2A deubiquitination,negative regulation of cell proliferation,nucleolus,nucleus,peptidase activity,protein K48-linked deubiquitination,protein binding,protein deubiquitination,protein modification process,proteolysis,regulation of cell cycle,regulation of cell growth,ubiquitin thiolesterase activity,ubiquitin-dependent protein catabolic process,ubiquitin-specific protease activity"			"G=718, T=783"	0.00001	7528.28		"G=356/362, T=383/400"	3	
chr3:52437748	A/C	A	SNV		BAP1	exonic	1								50.23	p.(=)		1071	"A=0.4977, C=0.5023"		-	13	NM_004656.3	c.1413T>G	synonymous	-1.24				Ubiquitin carboxyl-terminal hydrolase	rs34736117		0.017 (ref)	2.00E-04	0.0574	0.0196	YES	"PR-DUB complex,chromatin binding,chromatin modification,cysteine-type peptidase activity,cytoplasm,intracellular,intracellular membrane-bounded organelle,monoubiquitinated histone H2A deubiquitination,negative regulation of cell proliferation,nucleolus,nucleus,peptidase activity,protein K48-linked deubiquitination,protein binding,protein deubiquitination,protein modification process,proteolysis,regulation of cell cycle,regulation of cell growth,ubiquitin thiolesterase activity,ubiquitin-dependent protein catabolic process,ubiquitin-specific protease activity"			"A=533, C=538"	0.00001	5017.56		"A=218/315, C=243/295"	1	
chr3:142178144	C/T	C	SNV		ATR	exonic	1								49.4	p.Arg2425Gln		2000	"C=0.506, T=0.494"		-	43	NM_001184.3	c.7274G>A	missense	-2.53	0.5	43	0	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2229032		0.12 (ref)	0.1578	0.0881	0.1342	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			"C=1012, T=988"	0.00001	9217.85		"C=474/538, T=482/506"	1	
chr3:142222284	A/G	A	SNV		ATR	exonic	1								56.46	p.(=)		1091	"A=0.4354, G=0.5646"		-	30	NM_001184.3	c.5208T>C	synonymous	0.03				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227931		0.352 (ref)	0.4189	0.2145	0.3496	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			"A=475, G=616"	0.00001	6198.26		"A=226/249, G=297/319"	1	
chr3:142277536	A/G	A	SNV		ATR	exonic	1								50.03	p.(=)		1997	"A=0.4997, G=0.5003"		-	8	NM_001184.3	c.1815T>C	synonymous	0.12				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227929		0.349 (ref)	0.414	0.2127	0.3458	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			"A=998, G=999"	0.00001	9394.51		"A=497/501, G=513/486"	1	
chr3:142277575	T/T	A	SNV		ATR	exonic	1								100	p.(=)		1800	"A=0.0, T=1.0"		-	8	NM_001184.3	c.1776T>A	synonymous	-0.09				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227930		0.382 (ref)	0.405	0.2043	0.337	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			"A=0, T=1800"	0.00001	27329.1		"A=0/0, T=900/900"	1	
chr3:142281612	G/G	A	SNV		ATR	exonic	1								100	p.Met211Thr		1829	"A=0.0, G=1.0"		-	4	NM_001184.3	c.632T>C	missense	0.55	1	81	0	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227928		0.383 (ref)	0.4045	0.2072	0.3377	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			"A=0, G=1829"	0.00001	27833.5		"A=0/0, G=869/960"	1	
chr3:142286995	C/T	C	SNV		ATR	exonic	1								46.75	p.Ala21Thr		2000	"C=0.5325, T=0.4675"		-	2	NM_001184.3	c.61G>A	missense	1.2	0.08	58	0.041	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"								"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			"C=1065, T=935"	0.00001	8433.88		"C=563/502, T=495/440"	1	
chr3:178952085	A/G	A	SNV		PIK3CA	exonic	1	Hotspot	Gain-of-function			HS	COSM249874;COSM775;COSM776		"C=0.00, G=57.03, T=0.00"	p.His1047Arg		1999	"A=0.4297, C=0.0, G=0.5703, T=0.0"		+	21	NM_006218.2	c.3140A>G	missense	2.33	0.01	29	0.639	"PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family"	rs121913279							"1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction"	"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE"	other	"A=859, C=0, G=1140, T=0"	0.00001	10864.7		"A=291/568, C=0/0, G=602/538, T=0/0"	"1,1,1"	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100	p.(=)		1464	"G=0.0, A=1.0"		+	14	NM_000142.4	c.1953G>A	synonymous	0.05				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs7688609		0.042 (ref)	8.00E-04	0.131	0.0449	YES	"ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development"	"Palifermin,Pazopanib"		"G=0, A=1464"	0.00001	22219.4		"G=0/0, A=769/695"	1	
chr4:55141051	GCCCGGATGGACATGA/GCCCGGATGGACATGA	GCCCAGATGGACATGA	SNV		PDGFRA	exonic	1					HS	COSM12418		"G=0.00, GCCCGGATGGACATGA=100.00"	p.(=)		1976	"GCCCAGATGGACATGA=0.0, G=0.0, GCCCGGATGGACATGA=1.0"		+	12	NM_006206.4	c.1701A>G	synonymous	"2.79,2.74,2.74,2.74,-5.31,2.74,2.21,0.99,2.74,2.74,0.41,2.64,2.31,-0.28,1.57,2.31"				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	"rs121913270,rs121913271,rs1873778,rs201503614"		0.037				YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		"GCCCAGATGGACATGA=0, G=0, GCCCGGATGGACATGA=1976"	0.00001	28702.7		"GCCCAGATGGACATGA=0/0, G=0/0, GCCCGGATGGACATGA=967/1009"	"3,1"	
chr4:55143577	A/A	G	SNV		PDGFRA	exonic	1								100	p.(=)		1770	"G=0.0, A=1.0"		+	13	NM_006206.4	c.1809G>A	synonymous	-4.08				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs10028020		0.194	0.0994	0.2964	0.1662	YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		"G=0, A=1770"	0.00001	26815.5		"G=0/0, A=904/866"	1	
chr4:55152040	T/T	C	SNV		PDGFRA	exonic	1								100	p.(=)		1988	"C=0.0, T=1.0"		+	18	NM_006206.4	c.2472C>T	synonymous	0.47				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs2228230		0.208 (ref)	0.1393	0.3134	0.1983	YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		"C=0, T=1988"	0.00001	30071.4		"C=0/0, T=1013/975"	2	
chr4:55602765	G/C	G	SNV		KIT	exonic	1								48.85	p.(=)		2000	"G=0.5115, C=0.4885"		+	18	NM_000222.2	c.2586G>C	synonymous	-0.49				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs3733542		0.144 (ref)	0.1253	0.3252	0.1931	YES	"ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"	"Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib"		"G=1023, C=977"	0.00001	9053.72		"G=486/537, C=421/556"	1	
chr5:38942449	A/A	G	SNV		RICTOR	exonic	1								100	p.Thr1695Ile		1773	"G=0.0, A=1.0"		-	38	NM_152756.4	c.5084C>T	missense	-0.73	0.49	89	0		rs61748204		0.018 (ref)	0.0214	0.0379	0.027	YES	"T cell costimulation,TORC2 complex,actin cytoskeleton reorganization,cytosol,embryo development,fibroblast growth factor receptor signaling pathway,nerve growth factor receptor signaling pathway,phosphatidylinositol-mediated signaling,positive regulation of TOR signaling cascade,positive regulation of actin filament polymerization,positive regulation of peptidyl-tyrosine phosphorylation,protein binding,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of protein kinase B signaling cascade,ribosome binding"			"G=0, A=1773"	0.00001	26897		"G=0/0, A=884/889"	1	
chr5:67522722	C/T	C	SNV		PIK3R1	exonic	1								48.77	p.(=)		1345	"C=0.5123, T=0.4877"		+	2	NM_181523.2	c.219C>T	synonymous	-2.42				"RhoGAP domain,SH2 domain,SH3 domain"	rs706713		0.442 (ref)	0.234	0.4092	0.2933	YES	"1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction"	"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol"		"C=689, T=656"	0.00001	6060.37		"C=336/353, T=366/290"	1	
chr5:67588148	G/A	G	SNV		PIK3R1	exonic	1								47.12	p.Met326Ile		1997	"G=0.5288, A=0.4712"		+	8	NM_181523.2	c.978G>A	missense	1.5	0.42	10	0	"RhoGAP domain,SH2 domain,SH3 domain"	rs3730089		0.218 (ref)	0.1645	0.3822	0.2383	YES	"1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction"	"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol"		"G=1056, A=941"	0.00001	8529.5		"G=452/604, A=424/517"	1	
chr6:41903782	C/C	A	SNV		CCND3	exonic	1								100	p.Ser259Ala		1995	"A=0.0, C=1.0"		-	5	NM_001760.4	c.775T>G	missense	-0.25	0.59	99	0	Cyclin	rs1051130		0.415 (ref)	0.4535	0.2238	0.3757	YES	"T cell proliferation,cell division,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,membrane,nucleus,positive regulation of cyclin-dependent protein kinase activity,positive regulation of protein phosphorylation,protein binding,protein kinase binding,regulation of cell cycle,signal transduction"			"A=0, C=1995"	0.00001	30381.4		"A=0/0, C=916/1079"	1	
chr6:152129077	T/C	T	SNV		ESR1	exonic	1								46.59	p.(=)		1365	"T=0.5341, C=0.4659"		+	2	NM_001122740.1	c.30T>C	synonymous	-1.28				"Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger"	rs2077647		0.432 (ref)	0.4769	0.4828	0.4789	YES	"Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding"	"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate"		"T=729, C=636"	0.00001	5687.14		"T=400/329, C=351/285"	1	
chr6:152201875	C/C	T	SNV		ESR1	exonic	1								100	p.(=)		1684	"T=0.0, C=1.0"		+	4	NM_001122740.1	c.729T>C	synonymous	0.22				"Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger"	rs4986934		0.018 (ref)	0.04	0.0082	0.0292	YES	"Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding"	"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate"		"T=0, C=1684"	0.00001	25537.5		"T=0/0, C=835/849"	1	
chr6:152265522	G/C	G	SNV		ESR1	exonic	1								52.83	p.(=)		1995	"G=0.4717, C=0.5283"		+	5	NM_001122740.1	c.975G>C	synonymous	-0.42				"Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger"	rs1801132		0.262 (ref)	0.2257	0.1074	0.1856	YES	"Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding"	"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate"		"G=941, C=1054"	0.00001	9792.2		"G=486/455, C=578/476"	1	
chr7:6026775	C/C	T	SNV		PMS2	exonic	1								100	p.Lys541Glu		1808	"T=0.0, C=1.0"		-	11	NM_000535.5	c.1621A>G	missense	0.74	1	56	0	"DNA mismatch repair protein,Histidine kinase-"	rs2228006		0.121 (ref)	0.1543	0.0815	0.1296	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"	"Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester"		"T=0, C=1808"	0.00001	27332.5		"T=0/0, C=926/882"	4	
chr7:6026988	G/A	G	SNV		PMS2	exonic	1								48.8	p.Pro470Ser		2000	"G=0.512, A=0.488"		-	11	NM_000535.5	c.1408C>T	missense	0.39	0.51	74	0.002	"DNA mismatch repair protein,Histidine kinase-"	rs1805321		0.394 (ref)	0.4209	0.2819	0.3738	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"	"Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester"	non-pathogenic	"G=1024, A=976"	0.00001	9038.24		"G=490/534, A=484/492"	2	
chr7:6036980	C/C	G	SNV		PMS2	exonic	1								100	p.(=)		1991	"G=0.0, C=1.0"		-	7	NM_000535.5	c.780C>G	synonymous	-5.63				"DNA mismatch repair protein,Histidine kinase-"	rs1805319		0.157 (ref)	0.1852	0.1586	0.1762	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"	"Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester"	non-pathogenic	"G=0, C=1991"	0.00001	30290		"G=0/0, C=1144/847"	2	
chr7:55241707	G/A	G	SNV		EGFR	exonic	1					HS	COSM6252;COSM6253		"A=4.80, T=0.00"	p.Gly719Ser		2000	"G=0.952, A=0.048, T=0.0"		+	18	NM_005228.3	c.2155G>A	missense	2.75	0	56	1	"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs28929495							"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"	other	"G=1904, A=96, T=0"	0.00085	30.689		"G=884/1020, A=52/44, T=0/0"	"3,3"	
chr7:55242464	AGGAATTAAGAGAAGCAAC/AAAC	AGGAATTAAGAGAAGCAAC	INDEL		EGFR	exonic	15					HS	COSM6223;COSM24869		"AAAC=4.21, A=0.00"	p.Glu746_Ala750del		1973	"AGGAATTAAGAGAAGCAAC=0.9579, AAAC=0.0421, A=0.0"		+	19	NM_005228.3	c.2235_2249delGGAATTAAGAGAAGC	nonframeshiftDeletion	"2.16,1.4,2.68,0.98,-0.2,0.39,2.07,-1.46,-0.61,2.56,0.07,2.56,2.07,0.39,2.56,2.56,-0.63,2.07,2.56"				"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	"rs121913229,rs121913421,rs121913422,rs121913423,rs121913424,rs121913425,rs121913426,rs121913427,rs121913433,rs121913435,rs121913436,rs121913437,rs121913438,rs121913439,rs121913440,rs121913441,rs121913442"							"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"	untested	"AGGAATTAAGAGAAGCAAC=1890, AAAC=83, A=0"	0.03544	14.5048		"AGGAATTAAGAGAAGCAAC=998/892, AAAC=51/32, A=0/0"	"2,2"	
chr7:55249071	C/T	C	SNV		"EGFR,EGFR-AS1"	"exonic, exonic_nc"	1					HS	COSM6240		4.7	p.Thr790Met		2000	"C=0.953, T=0.047"		"+, -"	20	"NM_005228.3, NR_047551.1"	c.2369C>T	missense	2.8	0	81	1	"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs121434569							"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"	pathogenic	"C=1906, T=94"	0.00171	27.6608		"C=968/938, T=37/57"	1	
chr7:55259515	TG/GG	TG	SNV		EGFR	exonic	1	Hotspot	Gain-of-function			HS	COSM29578;COSM6224;COSM133630;COSM12429		"AG=0.00, GG=5.26, GA=0.00, GT=0.00"	p.Leu858Arg		1996	"TG=0.9474, AG=0.0, GG=0.0526, GA=0.0, GT=0.0"		+	21	NM_005228.3	c.2573T>G	missense	"2.18,2.69"	0	102	1	"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs121434568							"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"	other	"TG=1891, AG=0, GG=105, GA=0, GT=0"	0.00002	46.2286		"TG=894/997, AG=0/0, GG=51/54, GA=0/0, GT=0/0"	"1,1,1,1"	
chr7:55259524	T/A	T	SNV		EGFR	exonic	1	Hotspot	Gain-of-function			HS	COSM6213;COSM12374		"A=5.55, G=0.00"	p.Leu861Gln		2000	"T=0.9445, A=0.0555, G=0.0"		+	21	NM_005228.3	c.2582T>A	missense	2.22	0.01	113	0.999	"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs121913444							"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"	untested	"T=1889, A=111, G=0"	0.00001	59.7791		"T=882/1007, A=50/61, G=0/0"	"1,1"	
chr7:55266417	C/C	T	SNV		EGFR	exonic	1								100	p.(=)		1997	"T=0.0, C=1.0"		+	23	NM_005228.3	c.2709T>C	synonymous	-1.92				"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs1140475		0.095 (ref)	0.1267	0.0801	0.1109	YES	"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"		"T=0, C=1997"	0.00001	30428.6		"T=0/0, C=1094/903"	1	
chr7:140449150	T/C	T	SNV		BRAF	exonic	1								34.5	p.(=)		2000	"T=0.655, C=0.345"		-	16	NM_004333.4	c.1929A>G	synonymous	-0.01				"C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain"	rs9648696		0.28 (ref)	0.1463	0.3409	0.32	YES	"ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome"	"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib"		"T=1310, C=690"	0.00001	5130.44		"T=664/646, C=345/345"	2	
chr7:140453136	ACTG/TCTG	ACTG	SNV		BRAF	exonic	1	Hotspot	Gain-of-function			HS	COSM26504;COSM6137;COSM18443;COSM476;COSM1583011;COSM474;COSM249889;COSM473;COSM1127;COSM1735763		"ACTGTAGCTAGACCAAAATCTG=0.00, CCTG=0.00, GCTG=0.00, TCTG=66.88, CGTG=0.00, CTTG=0.00, TGTG=0.00, TTTG=0.00, CTCG=0.00, TTTA=0.00"	p.Val600Glu		1996	"ACTG=0.3312, ACTGTAGCTAGACCAAAATCTG=0.0, CCTG=0.0, GCTG=0.0, TCTG=0.6688, CGTG=0.0, CTTG=0.0, TGTG=0.0, TTTG=0.0, CTCG=0.0, TTTA=0.0"		-	15	NM_004333.4	c.1799T>A	missense	"2.17,2.69,2.17,2.69"	0	121	0.971	"C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain"	"rs113488022,rs121913227,rs121913374,rs121913375,rs121913377,rs121913378"							"ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome"	"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib"	"other,pathogenic"	"ACTG=661, ACTGTAGCTAGACCAAAATCTG=0, CCTG=0, GCTG=0, TCTG=1335, CGTG=0, CTTG=0, TGTG=0, TTTG=0, CTCG=0, TTTA=0"	0.00001	14079.6		"ACTG=299/362, ACTGTAGCTAGACCAAAATCTG=0/0, CCTG=0/0, GCTG=0/0, TCTG=598/737, CGTG=0/0, CTTG=0/0, TGTG=0/0, TTTG=0/0, CTCG=0/0, TTTA=0/0"	"1,1,1,1,1,1,1,1,1,1"	
chr8:90958422	T/C	T	SNV		NBN	exonic	1								49.62	p.(=)		1999	"T=0.5038, C=0.4962"		-	13	NM_002485.4	c.2016A>G	synonymous	-1.06				"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs1061302		0.328 (ref)	0.3132	0.2276	0.2842	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			"T=1007, C=992"	0.00001	9281.65		"T=498/509, C=518/474"	1	
chr8:90967711	A/G	A	SNV		NBN	exonic	1								50.95	p.(=)		2000	"A=0.4905, G=0.5095"		-	10	NM_002485.4	c.1197T>C	synonymous	-0.48				"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs709816		0.424 (ref)	0.3559	0.2473	0.4903	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			"A=981, G=1019"	0.00001	9691.53		"A=539/442, G=589/430"	1	
chr8:90990479	C/G	C	SNV		NBN	exonic	1								51.38	p.Glu185Gln		1300	"C=0.4862, G=0.5138"		-	5	NM_002485.4	c.553G>C	missense	0.09	1	29	0	"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs1805794		0.333 (ref)	0.3136	0.2338	0.2866	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			"C=632, G=668"	0.00001	6359.86		"C=323/309, G=333/335"	1	
chr8:90995019	C/T	C	SNV		NBN	exonic	1								45.4	p.(=)		2000	"C=0.546, T=0.454"		-	2	NM_002485.4	c.102G>A	synonymous	-0.39				"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs1063045		0.35 (ref)	0.3147	0.3103	0.3132	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			"C=1092, T=908"	0.00001	8039.4		"C=559/533, T=461/447"	1	
chr8:128752846	C/T	C	SNV		MYC	exonic	1								22.75	p.Ala336Val		2000	"C=0.7725, T=0.2275"		+	3	NM_002467.4	c.1007C>T	missense	2.52	0	64	0.983	"Helix-loop-helix DNA-binding domain,Myc amino-terminal region,Myc leucine zipper domain"								"DNA binding,E-box binding,MAPKKK cascade,branching involved in ureteric bud morphogenesis,canonical Wnt receptor signaling pathway,cell cycle arrest,cellular iron ion homeostasis,cellular response to UV,cellular response to drug,chromatin remodeling,chromosome organization,energy reserve metabolic process,fibroblast apoptosis,negative regulation of apoptotic process,negative regulation of cell division,negative regulation of fibroblast proliferation,negative regulation of monocyte differentiation,negative regulation of stress-activated MAPK cascade,negative regulation of transcription from RNA polymerase II promoter,nucleolus,nucleoplasm,nucleus,oxygen transport,positive regulation of DNA biosynthetic process,positive regulation of cell proliferation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of mesenchymal cell proliferation,positive regulation of metanephric cap mesenchymal cell proliferation,positive regulation of response to DNA damage stimulus,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex,protein complex binding,regulation of telomere maintenance,repressing transcription factor binding,response to DNA damage stimulus,response to drug,response to gamma radiation,response to growth factor stimulus,sequence-specific DNA binding transcription factor activity,spindle,transcription factor binding"			"C=1545, T=455"	0.00001	2511.8		"C=761/784, T=230/225"	1	
chr9:98209594	G/A	G	SNV		PTCH1	exonic	1								31.55	p.Pro1315Leu		1198	"G=0.6845, A=0.3155"		-	23	NM_000264.3	c.3944C>T	missense	2.51	0	98	0.906	Patched family	rs357564		0.382 (ref)	0.3298	0.2389	0.2993	YES	"Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development"			"G=820, A=378"	0.00001	2652.72		"G=376/444, A=180/198"	6	
chr9:98229389	C/G	C	SNV		"LOC100507346,PTCH1"	"intronic, exonic_nc"	1								66.1			1994	"C=0.339, G=0.661"		"-, +"		"NM_000264.3, NR_038982.1"			-0.28				Patched family	rs2066829		0.399 (ref)	0.3645	0.3715	0.4539	YES	"Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development"			"C=676, G=1318"	0.00001	14673.7		"C=348/328, G=671/647"	2	
chr9:135782221	T/C	T	SNV		TSC1	exonic	1								33	p.(=)		2000	"T=0.67, C=0.33"		-	14	NM_000368.4	c.1335A>G	synonymous	0.43				Hamartin protein	rs7862221		0.14 (ref)	0.1463	0.219	0.1709	YES	"GTPase activating protein binding,GTPase regulator activity,TSC1-TSC2 complex,actin filament,activation of Rho GTPase activity,cardiac muscle cell differentiation,cell cortex,cell cycle arrest,cell projection organization,cell-matrix adhesion,cerebral cortex development,chaperone binding,cytoplasm,cytosol,embryo development,growth cone,hippocampus development,insulin receptor signaling pathway,kidney development,lamellipodium,membrane,membrane fraction,microsome,myelination,negative regulation of TOR signaling cascade,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of translation,nervous system development,neural tube closure,positive regulation of focal adhesion assembly,potassium ion transport,protein N-terminus binding,protein binding,protein complex,protein heterooligomerization,protein stabilization,rRNA export from nucleus,regulation of actin cytoskeleton organization,regulation of cell-matrix adhesion,regulation of phosphoprotein phosphatase activity,regulation of protein kinase activity,regulation of stress fiber assembly,regulation of translation,response to insulin stimulus,synapse organization"		untested	"T=1340, C=660"	0.00001	4764.82		"T=632/708, C=325/335"	2	
chr9:135786904	A/G	A	SNV		TSC1	exonic	1								33.97	p.Met322Thr		1999	"A=0.6603, G=0.3397"		-	10	NM_000368.4	c.965T>C	missense	0.82	0.22	81	0	Hamartin protein	rs1073123		0.136 (ref)	0.1378	0.2195	0.1655	YES	"GTPase activating protein binding,GTPase regulator activity,TSC1-TSC2 complex,actin filament,activation of Rho GTPase activity,cardiac muscle cell differentiation,cell cortex,cell cycle arrest,cell projection organization,cell-matrix adhesion,cerebral cortex development,chaperone binding,cytoplasm,cytosol,embryo development,growth cone,hippocampus development,insulin receptor signaling pathway,kidney development,lamellipodium,membrane,membrane fraction,microsome,myelination,negative regulation of TOR signaling cascade,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of translation,nervous system development,neural tube closure,positive regulation of focal adhesion assembly,potassium ion transport,protein N-terminus binding,protein binding,protein complex,protein heterooligomerization,protein stabilization,rRNA export from nucleus,regulation of actin cytoskeleton organization,regulation of cell-matrix adhesion,regulation of phosphoprotein phosphatase activity,regulation of protein kinase activity,regulation of stress fiber assembly,regulation of translation,response to insulin stimulus,synapse organization"		non-pathogenic	"A=1320, G=679"	0.00001	4997.5		"A=704/616, G=338/341"	1	
chr9:139391636	G/A	G	SNV		NOTCH1	exonic	1								65.92	p.(=)		1998	"G=0.3408, A=0.6592"		-	34	NM_017617.3	c.6555C>T	synonymous	-0.09				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs2229974		0.305 (ref)	0.4467	0.3639	0.4187	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			"G=681, A=1317"	0.00001	14651.2		"G=432/249, A=834/483"	1	
chr9:139397707	G/A	G	SNV		NOTCH1	exonic	1								66.42	p.(=)		1998	"G=0.3358, A=0.6642"		-	27	NM_017617.3	c.5094C>T	synonymous	-0.82				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs10521		0.417 (ref)	0.3534	0.4829	0.408	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			"G=671, A=1327"	0.00001	14831.5		"G=376/295, A=796/531"	1	
chr9:139401289	C/G	C	SNV		NOTCH1	exonic	1								31.45	p.(=)		2000	"C=0.6855, G=0.3145"		-	23	NM_017617.3	c.3780G>C	synonymous	0.18				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs201354526		0.005 (ref)	1.00E-04	0.02	0.0067		"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			"C=1371, G=629"	0.00001	4395.49		"C=738/633, G=326/303"	3	
chr9:139407932	G/G	A	SNV		NOTCH1	exonic	1								100	p.(=)		1991	"A=0.0, G=1.0"		-	14	NM_017617.3	c.2265T>C	synonymous	-1.25				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs2229971		0.444 (ref)	0.2858	0.3844	0.3975	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			"A=0, G=1991"	0.00001	30235.8		"A=0/0, G=1045/946"	1	
chr9:139413269	G/A	G	SNV		"MIR4673,NOTCH1"	"exonic, downstream"	1								66.72	p.(=)		1998	"G=0.3328, A=0.6672"		-	6	"NM_017617.3, NR_039820.1"	c.873C>T	synonymous	2.48				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs143654474		0.004 (ref)	0	0.0158	0.0053		"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			"G=665, A=1333"	0.00001	14911.7		"G=389/276, A=822/511"	1	
chr9:139418260	G/G	A	SNV		NOTCH1	exonic	1								100	p.(=)		1157	"A=0.0, G=1.0"		-	3	NM_017617.3	c.312T>C	synonymous	-1.16				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs4489420		0.293 (ref)	0.4711	0.1191	0.3913	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			"A=0, G=1157"	0.00001	17621.7		"A=0/0, G=675/482"	1	
chr10:43613843	G/T	G	SNV		RET	exonic	1								68.1	p.(=)		1856	"G=0.319, T=0.681"		+	13	NM_020975.4	c.2307G>T	synonymous	1.34				"Cadherin domain,Protein kinase domain,Protein tyrosine kinase"	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	"ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development"	"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib"	untested	"G=592, T=1264"	0.00001	13579		"G=301/291, T=565/699"	1	
chr10:123298158	T/C	T	SNV		FGFR2	exonic	1								50.59	p.(=)		1107	"T=0.4941, C=0.5059"		-	6	NM_000141.4	c.696A>G	synonymous	0.96				"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs1047100		0.176 (ref)	0.2236	0.2522	0.2333	YES	"ATP binding,Golgi apparatus,angiogenesis,apoptotic process,axonogenesis,bone development,bone mineralization,bone morphogenesis,branch elongation involved in salivary gland morphogenesis,branching involved in embryonic placenta morphogenesis,branching involved in prostate gland morphogenesis,branching involved in salivary gland morphogenesis,branching morphogenesis of a nerve,bud elongation involved in lung branching,cell cortex,cell fate commitment,cell surface,cell-cell signaling,cytoplasm,cytoplasmic membrane-bounded vesicle,digestive tract development,embryonic digestive tract morphogenesis,embryonic organ development,embryonic organ morphogenesis,embryonic pattern specification,epidermis morphogenesis,epithelial cell differentiation,epithelial cell proliferation involved in salivary gland morphogenesis,excitatory synapse,extracellular matrix,extracellular region,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,fibroblast growth factor-activated receptor activity,gland morphogenesis,hair follicle morphogenesis,heparin binding,in utero embryonic development,inner ear morphogenesis,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,lacrimal gland development,lateral sprouting from an epithelium,limb bud formation,lung alveolus development,lung development,lung lobe morphogenesis,lung-associated mesenchyme development,mammary gland bud formation,membrane,membranous septum morphogenesis,mesenchymal cell differentiation,mesenchymal cell differentiation involved in lung development,mesenchymal cell proliferation involved in lung development,midbrain development,morphogenesis of embryonic epithelium,multicellular organism growth,negative regulation of transcription from RNA polymerase II promoter,nucleotide binding,nucleus,odontogenesis,orbitofrontal cortex development,organ growth,organ morphogenesis,otic vesicle formation,outflow tract septum morphogenesis,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Wnt receptor signaling pathway,positive regulation of canonical Wnt receptor signaling pathway,positive regulation of cardiac muscle cell proliferation,positive regulation of cell cycle,positive regulation of cell division,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of epithelial cell proliferation involved in lung morphogenesis,positive regulation of mesenchymal cell proliferation,positive regulation of phospholipase activity,positive regulation of transcription from RNA polymerase II promoter,post-embryonic development,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,prostate gland morphogenesis,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,pyramidal neuron development,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of branching involved in prostate gland morphogenesis,regulation of cell fate commitment,regulation of fibroblast growth factor receptor signaling pathway,regulation of morphogenesis of a branching structure,regulation of multicellular organism growth,regulation of osteoblast differentiation,regulation of osteoblast proliferation,regulation of smooth muscle cell differentiation,regulation of smoothened signaling pathway,reproductive structure development,skeletal system morphogenesis,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,ureteric bud development,ventricular cardiac muscle tissue morphogenesis,ventricular zone neuroblast division"	"4-4-(1-Amino-1-Methylethyl)Phenyl-5-Chloro-N-4-(2-Morpholin-4-Ylethyl)PhenylPyrimidin-2-Amine,Palifermin,SU4984,Thalidomide"		"T=547, C=560"	0.00001	5286.5		"T=279/268, C=298/262"	1	
chr11:534242	A/G	A	SNV		HRAS	exonic	1								49.19	p.(=)		1289	"A=0.5081, G=0.4919"		-	2	NM_001130442.1	c.81T>C	synonymous	0				"Miro-like protein,Ras family"	rs12628		0.297 (ref)	0.3441	0.3749	0.3545	YES	"GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,apoptotic process,axon guidance,blood coagulation,cell cycle arrest,cell surface receptor linked signaling pathway,cellular senescence,chemotaxis,cytoplasm,cytosol,endocytosis,epidermal growth factor receptor signaling pathway,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,leukocyte migration,membrane fraction,microsome,mitotic cell cycle G1/S transition checkpoint,negative regulation of cell proliferation,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,protein C-terminus binding,protein binding,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,social behavior,soluble fraction,striated muscle cell differentiation,synaptic transmission,visual learning"	"Guanosine-5'-Diphosphate,Guanosine-5'-Triphosphate,Hexane-1,6-Diol,N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE,Trifluoroethanol"		"A=655, G=634"	0.00001	5866.31		"A=296/359, G=336/298"	4	
chr11:69633633	C/A	C	SNV		FGF3	exonic	1								44.78	p.(=)		469	"C=0.5522, A=0.4478"		-	1	NM_005247.2	c.69G>T	synonymous	-0.21				Fibroblast growth factor	rs41538178		0.079 (ref)				YES	"Golgi apparatus,anatomical structure morphogenesis,cell differentiation,cell-cell signaling,cytoplasm,extracellular region,fibroblast growth factor receptor signaling pathway,growth factor activity,insulin receptor signaling pathway,multicellular organismal development,negative regulation of cardiac muscle tissue development,organ induction,positive regulation of cell division,positive regulation of cell proliferation,protein binding,semicircular canal morphogenesis,signal transduction,tail morphogenesis,thymus development"			"C=259, A=210"	0.00001	1836.82		"C=104/155, A=68/142"	1	
chr11:108122592	C/G	C	SNV		ATM	exonic	1								48.57	p.Leu546Val		1997	"C=0.5143, G=0.4857"		+	11	NM_000051.3	c.1636C>G	missense	-0.13	0.01	32	0.539	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs2227924		0.014 (ref)	1.00E-04	0.0513	0.0175	YES	"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			"C=1027, G=970"	0.00001	8957.6		"C=487/540, G=473/497"	1	
chr11:108127010	C/T	C	SNV		ATM	exonic	1								49	p.(=)		2000	"C=0.51, T=0.49"		+	14	NM_000051.3	c.2193C>T	synonymous	-1.05				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs2229019		0.014 (ref)	1.00E-04	0.0513	0.0175	YES	"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			"C=1020, T=980"	0.00001	9096.65		"C=464/556, T=445/535"	1	
chr11:108139183	A/G	A	SNV		ATM	exonic	1								49.3	p.(=)		2000	"A=0.507, G=0.493"		+	18	NM_000051.3	c.2685A>G	synonymous	-2.45				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs3218687		0.011 (ref)	1.00E-04	0.0473	0.0161	YES	"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			"A=1014, G=986"	0.00001	9188.51		"A=479/535, G=512/474"	1	
chr11:108150316	A/G	A	SNV		ATM	exonic	1								48.95	p.Gln1128Arg		2000	"A=0.5105, G=0.4895"		+	23	NM_000051.3	c.3383A>G	missense	0.43	0	43	0.905	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs2229020		0.005 (ref)	1.00E-04	0.0211	0.0072		"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			"A=1021, G=979"	0.00001	9077.2		"A=500/521, G=465/514"	1	
chr11:108183167	G/G	A	SNV		ATM	exonic	1								100	p.Asn1983Ser		2000	"A=0.0, G=1.0"		+	40	NM_000051.3	c.5948A>G	missense	-0.19	1	46	0	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs659243		0.0 (ref)					"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			"A=0, G=2000"	0.00001	30497.1		"A=0/0, G=1147/853"	2	
chr11:108198391	T/C	T	SNV		ATM	exonic	1								53.04	p.Leu2332Pro		1925	"T=0.4696, C=0.5304"		+	48	NM_000051.3	c.6995T>C	missense	0.9	0.25	98	0.005	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs4988111		0.005 (ref)	1.00E-04	0.0248	0.0085		"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			"T=904, C=1021"	0.00001	9902.25		"T=461/443, C=549/472"	2	
chr11:125525195	G/G	A	SNV		CHEK1	exonic	1								100	p.Ile471Val		1995	"A=0.0, G=1.0"		+	13	NM_001274.5	c.1411A>G	missense	0.45	1	29	0	"Protein kinase domain,Protein tyrosine kinase"	rs506504		0.017 (ref)	0.0363	0.0064	0.0262	YES	"ATP binding,DNA damage checkpoint,DNA damage induced protein phosphorylation,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,G2/M transition of mitotic cell cycle,cell cycle,cell cycle checkpoint,cellular response to caffeine,cellular response to mechanical stimulus,cellular response to organic substance,centrosome,chromatin,chromatin-mediated maintenance of transcription,chromosome, telomeric region,condensed nuclear chromosome,cytoplasm,cytoskeleton,histone H3-T11 phosphorylation,histone kinase activity (H3-T11 specific),negative regulation of mitosis,nucleoplasm,nucleotide binding,nucleus,peptidyl-threonine phosphorylation,protein binding,protein serine/threonine kinase activity,regulation of S phase,regulation of double-strand break repair via homologous recombination,regulation of histone H3-K9 acetylation,regulation of mitotic centrosome separation,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,replication fork,replicative senescence,response to DNA damage stimulus"	"(2R)-1-(5,6-DIPHENYL-7H-PYRROLO2,3-DPYRIMIDIN-4-YL)AMINOPROPAN-2-OL,(2R)-3-{(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO2,3-DPYRIMIDIN-4-YLIDENEAMINO}PROPANE-1,2-DIOL,(2S)-1-AMINO-3-(5-NITROQUINOLIN-8-YL)AMINOPROPAN-2-OL,(3-ENDO)-8-METHYL-8-AZABICYCLO3.2.1OCT-3-YL 1H-PYRROLO2,3-BPYRIDINE-3-CARBOXYLATE,(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE,(5,6-DIPHENYL-FURO2,3-DPYRIMIDIN-4-YLAMINO)-ACETIC,(5-{3-5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL,1-(2S)-4-(5-BROMO-1H-PYRAZOLO3,4-BPYRIDIN-4-YL)MORPHOLIN-2-YLMETHANAMINE,1-(2S)-4-(5-phenyl-1H-pyrazolo3,4-bpyridin-4-yl)morpholin-2-ylmethanamine,1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-2-(DIMETHYLAMINO)-1-METHYLETHOXYPYRAZIN-2-YL}UREA,18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE,2,2'-{9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYLBIS(OXY)}DIACETIC ACID,2-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)AMINOETHANOL,2-(cyclohexylamino)benzoic acid,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,2-5,6-BIS-(4-METHOXY-PHENYL)-FURO2,3-DPYRIMIDIN-4-YLAMINO-ETHANOL,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,3-AMINO-3-BENZYL-4.3.0BICYCLO-1,6-DIAZANONAN-2-ONE,4-(3S)-1-AZABICYCLO2.2.2OCT-3-YLAMINO-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,4-(6-{(4-METHYLCYCLOHEXYL)AMINOMETHYL}-1,4-DIHYDROINDENO1,2-CPYRAZOL-3-YL)BENZOIC ACID,4-3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL-2-METHOXYPHENOL,4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl(phenyl)methanone,5,6,7,8-TETRAHYDRO1BENZOTHIENO2,3-DPYRIMIDIN-4(3H)-ONE,5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO4,3-CQUINOLIN-4-ONE,6-MORPHOLIN-4-YL-9H-PURINE,N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-1,3THIAZOLO5,4-CAZEPIN-2-YL)ACETAMIDE,N-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)GLYCINE,N-{5-4-(4-METHYLPIPERAZIN-1-YL)PHENYL-1H-PYRROLO2,3-BPYRIDIN-3-YL}NICOTINAMIDE,REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO1,2,3-FG:3',2',1'-KLPYRROLO3,4-I1,6BENZODIAZOCINE-1,3(2H)-DIONE"		"A=0, G=1995"	0.00001	30348.5		"A=0/0, G=960/1035"	1	
chr12:12871099	G/G	T	SNV		CDKN1B	exonic	1								100	p.Val109Gly		1991	"T=0.0, G=1.0"		+	1	NM_004064.4	c.326T>G	missense	-0.16	0.08	109	0.047	Cyclin-dependent kinase inhibitor	rs2066827		0.295 (ref)	0.2378	0.3069	0.3919	YES	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,activation of caspase activity,autophagic cell death,cell cycle,cell cycle arrest,cell cycle checkpoint,cellular response to antibiotic,cellular response to lithium ion,cellular response to organic cyclic compound,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase inhibitor activity,cysteine-type endopeptidase activator activity involved in apoptotic process,cytoplasm,cytosol,endosome,fibroblast growth factor receptor signaling pathway,induction of apoptosis,inner ear development,kinase activity,mitotic cell cycle,mitotic cell cycle arrest,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of cellular component movement,negative regulation of cyclin-dependent protein kinase activity,negative regulation of epithelial cell proliferation involved in prostate gland development,negative regulation of kinase activity,negative regulation of mitotic cell cycle,negative regulation of phosphorylation,negative regulation of transcription, DNA-dependent,nerve growth factor receptor signaling pathway,nucleoplasm,nucleus,phosphatidylinositol-mediated signaling,phosphorylation,positive regulation of cell death,positive regulation of cell proliferation,positive regulation of microtubule polymerization,positive regulation of protein catabolic process,potassium ion transport,protein binding,protein kinase inhibitor activity,protein phosphatase binding,regulation of cyclin-dependent protein kinase activity,sensory perception of sound,transforming growth factor beta receptor, cytoplasmic mediator activity"			"T=0, G=1991"	0.00001	30349.9		"T=0/0, G=1038/953"	1	
chr12:25368462	T/T	C	SNV		KRAS	exonic	1								100	p.(=)		1987	"C=0.0, T=1.0"		-	5	NM_033360.3	c.483G>A	synonymous	1.06				"Miro-like protein,Ras family"	rs4362222		0.0 (ref)	0	0.0043	0.0015		"GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior"	"(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE"		"C=0, T=1987"	0.00001	30054.8		"C=0/0, T=1055/932"	3	
chr12:56360876	G/A	G	SNV		CDK2	exonic	1								49.21	p.(=)		1329	"G=0.5079, A=0.4921"		+	1	NM_001798.3	c.84G>A	synonymous	0.08				"Protein kinase domain,Protein tyrosine kinase"	rs2069398		0.101 (ref)	0.0773	0.2783	0.1454	YES	"ATP binding,Cajal body,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA repair,DNA replication,G1/S transition of mitotic cell cycle,G2 phase of mitotic cell cycle,G2/M transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,Ras protein signal transduction,S phase of mitotic cell cycle,X chromosome,Y chromosome,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,blood coagulation,cell cycle,cell cycle checkpoint,cell division,cellular response to nitric oxide,centrosome,centrosome duplication,chromosome, telomeric region,condensed chromosome,cyclin binding,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytoskeleton,cytosol,endosome,histone kinase activity,histone phosphorylation,kinase activity,meiosis,metal ion binding,mitosis,mitotic cell cycle,mitotic cell cycle G1/S transition DNA damage checkpoint,nucleoplasm,nucleotide binding,nucleus,phosphorylation,positive regulation of cell proliferation,positive regulation of transcription, DNA-dependent,potassium ion transport,protein binding,protein kinase activity,protein phosphorylation,regulation of DNA replication,regulation of gene silencing,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,transcription factor complex,traversing start control point of mitotic cell cycle"	"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO15.6.2.16,9.1,12,15.0,2,7.0,21,25HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE,(2R)-1-(DIMETHYLAMINO)-3-{4-(6-{2-FLUORO-5-(TRIFLUOROMETHYL)PHENYLAMINO}PYRIMIDIN-4-YL)AMINOPHENOXY}PROPAN-2-OL,(2R)-1-4-({4-(2,5-DICHLOROPHENYL)AMINOPYRIMIDIN-2-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2R)-1-4-({6-(2,6-DIFLUOROPHENYL)AMINOPYRIMIDIN-4-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2R)-1-{4-(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINOPHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,(2R)-2-({9-(1-methylethyl)-6-(4-pyridin-2-ylbenzyl)amino-9H-purin-2-yl}amino)butan-1-ol,(2R)-2-{4-(benzylamino)-8-(1-methylethyl)pyrazolo1,5-a1,3,5triazin-2-ylamino}butan-1-ol,(2S)-1-4-({4-(2,5-DICHLOROPHENYL)AMINOPYRIMIDIN-2-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2S)-1-4-({6-(2,6-DIFLUOROPHENYL)AMINOPYRIMIDIN-4-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2S)-1-{4-(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINOPHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,(2S)-N-(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE-2-4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYLPROPANAMIDE,(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE,(2e,3s)-3-Hydroxy-5'-(4-Hydroxypiperidin-1-Yl)Sulfonyl-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One,(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-1benzothieno3,2-e1,4diazepin-5-one,(4-AMINO-2-{1-(METHYLSULFONYL)PIPERIDIN-4-YLAMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE,(4E)-N-(4-fluorophenyl)-4-(phenylcarbonyl)imino-4H-pyrazole-3-carboxamide,(5-Chloropyrazolo1,5-aPyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine,(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo1,5-apyrimidin-3-yl)methanol,(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO1,5-APYRIMIDIN-7-AMINE,1-(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy-3-Methyl-2-Butanol,1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID,1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO1,2-CPYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA,1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO2,1-AISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA,1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO1,2-APYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO}PHENOXY)PROPAN-2-OL,1-4-(AMINOSULFONYL)PHENYL-1,6-DIHYDROPYRAZOLO3,4-EINDAZOLE-3-CARBOXAMIDE,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo4,3-hquinazoline-3-carboxylic acid,2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE,2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO1,2-CPYRAZOL-5-YL)ACETAMIDE,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo1,2-aPyridin-3-Yl-Phenyl-Methanone,2-Amino-6-Chloropyrazine,2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE,2-Trans-(4-Aminocyclohexyl)Amino-6-(Benzyl-Amino)-9-Cyclopentylpurine,2-{4-4-({4-2-methyl-1-(1-methylethyl)-1H-imidazol-5-ylpyrimidin-2-yl}amino)phenylpiperazin-1-yl}-2-oxoethanol,3-((3-bromo-5-o-tolylpyrazolo1,5-apyrimidin-7-ylamino)methyl)pyridine 1-oxide,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,3-({2-(4-{6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YLAMINO}PHENYL)SULFONYLETHYL}AMINO)PROPAN-1-OL,3-4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino-Phenol,3-Pyridin-4-Yl-2,4-Dihydro-Indeno1,2-.C.Pyrazole,3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo1,5-apyridin-7-amine,3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo1,2-apyridin-8-amine,3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,3-methyl-N-(pyridin-4-ylmethyl)imidazo1,2-apyrazin-8-amine,3-{(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINOMETHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE,3-{4-(AMINO(IMINO)METHYLAMINOSULFONYL)ANILINOMETHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE,4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene-1,3-Dihydro-Indol-2-One,4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl-(4-Trifluoromethyl-Phenyl)-Amine,4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine,4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine,4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl-(3-Nitro-Phenyl)-Amine,4-(4-Imidazo1,2-aPyridin-3-Ylpyrimidin-2-Yl)AminoBenzenesulfonamide,4-(4-methoxy-1H-pyrrolo2,3-bpyridin-3-yl)pyrimidin-2-amine,4-(4-propoxy-1H-pyrrolo2,3-bpyridin-3-yl)pyrimidin-2-amine,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,4-(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINOBENZENESULFONAMIDE,4-(6-Amino-4-Pyrimidinyl)AminoBenzenesulfonamide,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,4-(6-chloropyrazin-2-yl)aminobenzenesulfonamide,4-(7-OXO-7H-THIAZOLO5,4-EINDOL-8-YLMETHYL)-AMINO-N-PYRIDIN-2-YL-BENZENESULFONAMIDE,4-(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYLPHENOL,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,4-({5-(4-AMINOCYCLOHEXYL)AMINO1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE,4-3-Hydroxyanilino-6,7-Dimethoxyquinazoline,4-4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino-Phenol,4-5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo1,5-aPyrimidin-7-Ylamino-N,N-Dimethylbenzenesulfonamide,4-METHYL-5-{(2E)-2-(4-MORPHOLIN-4-YLPHENYL)IMINO-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE,4-{(2,6-dichlorophenyl)carbonylamino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide,4-{(2,6-difluorophenyl)carbonylamino}-N-(3S)-piperidin-3-yl-1H-pyrazole-3-carboxamide,4-{(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYLAMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE,4-{4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YLAMINO}-N-METHYLBENZENESULFONAMIDE,4-{4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YLAMINO}BENZAMIDE,4-{5-(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL-2-FURYL}BENZENESULFONAMIDE,4-{5-(CYCLOHEXYLAMINO)1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YLAMINO}BENZENESULFONAMIDE,4-{5-(CYCLOHEXYLMETHOXY)1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YLAMINO}BENZENESULFONAMIDE,4-{5-(CYCLOHEXYLOXY)1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YLAMINO}BENZENESULFONAMIDE,4-{5-(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}BENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL-2-FURYL}-N-METHYLBENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}BENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}BENZOIC ACID,5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo1,5-apyrimidin-7-amine,5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,5-(2-AMINOETHYL)AMINO-6-FLUORO-3-(1H-PYRROL-2-YL)BENZOCDINDOL-2(1H)-ONE,5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,5-(4-AMINOCYCLOHEXYL)AMINO-7-(PROPAN-2-YLAMINO)PYRAZOLO1,5-APYRIMIDINE-3-CARBONITRILE,5-5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL-3-{1-(2-CHLOROPHENYL)ETHYLOXY}-2-THIOPHENECARBOXAMIDE,5-chloro-7-(1-methylethyl)aminopyrazolo1,5-apyrimidine-3-carbonitrile,5-hydroxynaphthalene-1-sulfonamide,5-{(2-Amino-9h-Purin-6-Yl)OxyMethyl}-2-Pyrrolidinone,6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo1,2-apyrazin-8-amine,6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-4(5H)-ONE,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO12.3.1.1~3,7~NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE,6-O-Cyclohexylmethyl Guanine,9-amino-5-(2-aminopyrimidin-4-yl)pyrido3',2':4,5pyrrolo1,2-cpyrimidin-4-ol,Double Oxidized Cysteine,Flavopiridol,HYDROXY(OXO)(3-{(2Z)-4-3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYLPYRIMIDIN-2(5H)-YLIDENEAMINO}PHENYL)AMMONIUM,Hymenialdisine,Indirubin-3'-Monoxime,Lysine Nz-Carboxylic Acid,N'-(Pyrrolidino2,1-BIsoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea,N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo1,5-apyrimidin-7-amine,N-(2-METHOXYETHYL)-4-({4-2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YLPYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE,N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,N-(4-{(3S)-3-(dimethylamino)pyrrolidin-1-ylcarbonyl}phenyl)-5-fluoro-4-2-methyl-1-(1-methylethyl)-1H-imidazol-5-ylpyrimidin-2-amine,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,N-3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YLBENZAMIDE,N-4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE,N-4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl-N'-Hydroxyimidoformamide,N-4-(2-Methylimidazo1,2-aPyridin-3-Yl)-2-PyrimidinylAcetamide,N-5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE,N-METHYL-4-{(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYLAMINO}BENZENESULFONAMIDE,N-METHYL-{4-2-(7-OXO-6,7-DIHYDRO-8H-1,3THIAZOLO5,4-EINDOL-8-YLIDENE)HYDRAZINOPHENYL}METHANESULFONAMIDE,N-cyclopropyl-4-pyrazolo1,5-bpyridazin-3-ylpyrimidin-2-amine,N-phenyl-1H-pyrazole-3-carboxamide,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OLOMOUCINE II,Olomoucine,PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE,Purvalanol,SU9516,Staurosporine,TRIAZOLOPYRIMIDINE,{(2,6-difluorophenyl)carbonylamino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide"		"G=675, A=654"	0.00001	6056.69		"G=364/311, A=336/318"	2	
chr12:56363357	G/A	G	SNV		CDK2	exonic	1								52.53	p.(=)		1386	"G=0.4747, A=0.5253"		+	5	NM_001798.3	c.585G>A	synonymous	1.59				"Protein kinase domain,Protein tyrosine kinase"	rs2069406		0.033 (ref)	0.001	0.1223	0.0421	YES	"ATP binding,Cajal body,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA repair,DNA replication,G1/S transition of mitotic cell cycle,G2 phase of mitotic cell cycle,G2/M transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,Ras protein signal transduction,S phase of mitotic cell cycle,X chromosome,Y chromosome,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,blood coagulation,cell cycle,cell cycle checkpoint,cell division,cellular response to nitric oxide,centrosome,centrosome duplication,chromosome, telomeric region,condensed chromosome,cyclin binding,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytoskeleton,cytosol,endosome,histone kinase activity,histone phosphorylation,kinase activity,meiosis,metal ion binding,mitosis,mitotic cell cycle,mitotic cell cycle G1/S transition DNA damage checkpoint,nucleoplasm,nucleotide binding,nucleus,phosphorylation,positive regulation of cell proliferation,positive regulation of transcription, DNA-dependent,potassium ion transport,protein binding,protein kinase activity,protein phosphorylation,regulation of DNA replication,regulation of gene silencing,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,transcription factor complex,traversing start control point of mitotic cell cycle"	"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO15.6.2.16,9.1,12,15.0,2,7.0,21,25HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE,(2R)-1-(DIMETHYLAMINO)-3-{4-(6-{2-FLUORO-5-(TRIFLUOROMETHYL)PHENYLAMINO}PYRIMIDIN-4-YL)AMINOPHENOXY}PROPAN-2-OL,(2R)-1-4-({4-(2,5-DICHLOROPHENYL)AMINOPYRIMIDIN-2-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2R)-1-4-({6-(2,6-DIFLUOROPHENYL)AMINOPYRIMIDIN-4-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2R)-1-{4-(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINOPHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,(2R)-2-({9-(1-methylethyl)-6-(4-pyridin-2-ylbenzyl)amino-9H-purin-2-yl}amino)butan-1-ol,(2R)-2-{4-(benzylamino)-8-(1-methylethyl)pyrazolo1,5-a1,3,5triazin-2-ylamino}butan-1-ol,(2S)-1-4-({4-(2,5-DICHLOROPHENYL)AMINOPYRIMIDIN-2-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2S)-1-4-({6-(2,6-DIFLUOROPHENYL)AMINOPYRIMIDIN-4-YL}AMINO)PHENOXY-3-(DIMETHYLAMINO)PROPAN-2-OL,(2S)-1-{4-(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINOPHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,(2S)-N-(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE-2-4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYLPROPANAMIDE,(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE,(2e,3s)-3-Hydroxy-5'-(4-Hydroxypiperidin-1-Yl)Sulfonyl-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One,(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-1benzothieno3,2-e1,4diazepin-5-one,(4-AMINO-2-{1-(METHYLSULFONYL)PIPERIDIN-4-YLAMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE,(4E)-N-(4-fluorophenyl)-4-(phenylcarbonyl)imino-4H-pyrazole-3-carboxamide,(5-Chloropyrazolo1,5-aPyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine,(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo1,5-apyrimidin-3-yl)methanol,(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO1,5-APYRIMIDIN-7-AMINE,1-(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy-3-Methyl-2-Butanol,1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID,1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO1,2-CPYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA,1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO2,1-AISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA,1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO1,2-APYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO}PHENOXY)PROPAN-2-OL,1-4-(AMINOSULFONYL)PHENYL-1,6-DIHYDROPYRAZOLO3,4-EINDAZOLE-3-CARBOXAMIDE,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo4,3-hquinazoline-3-carboxylic acid,2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE,2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO1,2-CPYRAZOL-5-YL)ACETAMIDE,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo1,2-aPyridin-3-Yl-Phenyl-Methanone,2-Amino-6-Chloropyrazine,2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE,2-Trans-(4-Aminocyclohexyl)Amino-6-(Benzyl-Amino)-9-Cyclopentylpurine,2-{4-4-({4-2-methyl-1-(1-methylethyl)-1H-imidazol-5-ylpyrimidin-2-yl}amino)phenylpiperazin-1-yl}-2-oxoethanol,3-((3-bromo-5-o-tolylpyrazolo1,5-apyrimidin-7-ylamino)methyl)pyridine 1-oxide,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,3-({2-(4-{6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YLAMINO}PHENYL)SULFONYLETHYL}AMINO)PROPAN-1-OL,3-4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino-Phenol,3-Pyridin-4-Yl-2,4-Dihydro-Indeno1,2-.C.Pyrazole,3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo1,5-apyridin-7-amine,3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo1,2-apyridin-8-amine,3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,3-methyl-N-(pyridin-4-ylmethyl)imidazo1,2-apyrazin-8-amine,3-{(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINOMETHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE,3-{4-(AMINO(IMINO)METHYLAMINOSULFONYL)ANILINOMETHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE,4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene-1,3-Dihydro-Indol-2-One,4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl-(4-Trifluoromethyl-Phenyl)-Amine,4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine,4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine,4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl-(3-Nitro-Phenyl)-Amine,4-(4-Imidazo1,2-aPyridin-3-Ylpyrimidin-2-Yl)AminoBenzenesulfonamide,4-(4-methoxy-1H-pyrrolo2,3-bpyridin-3-yl)pyrimidin-2-amine,4-(4-propoxy-1H-pyrrolo2,3-bpyridin-3-yl)pyrimidin-2-amine,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,4-(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINOBENZENESULFONAMIDE,4-(6-Amino-4-Pyrimidinyl)AminoBenzenesulfonamide,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,4-(6-chloropyrazin-2-yl)aminobenzenesulfonamide,4-(7-OXO-7H-THIAZOLO5,4-EINDOL-8-YLMETHYL)-AMINO-N-PYRIDIN-2-YL-BENZENESULFONAMIDE,4-(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYLPHENOL,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,4-({5-(4-AMINOCYCLOHEXYL)AMINO1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE,4-3-Hydroxyanilino-6,7-Dimethoxyquinazoline,4-4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino-Phenol,4-5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo1,5-aPyrimidin-7-Ylamino-N,N-Dimethylbenzenesulfonamide,4-METHYL-5-{(2E)-2-(4-MORPHOLIN-4-YLPHENYL)IMINO-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE,4-{(2,6-dichlorophenyl)carbonylamino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide,4-{(2,6-difluorophenyl)carbonylamino}-N-(3S)-piperidin-3-yl-1H-pyrazole-3-carboxamide,4-{(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYLAMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE,4-{4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YLAMINO}-N-METHYLBENZENESULFONAMIDE,4-{4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YLAMINO}BENZAMIDE,4-{5-(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL-2-FURYL}BENZENESULFONAMIDE,4-{5-(CYCLOHEXYLAMINO)1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YLAMINO}BENZENESULFONAMIDE,4-{5-(CYCLOHEXYLMETHOXY)1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YLAMINO}BENZENESULFONAMIDE,4-{5-(CYCLOHEXYLOXY)1,2,4TRIAZOLO1,5-APYRIMIDIN-7-YLAMINO}BENZENESULFONAMIDE,4-{5-(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}BENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL-2-FURYL}-N-METHYLBENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}BENZENESULFONAMIDE,4-{5-(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYLFURAN-2-YL}BENZOIC ACID,5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo1,5-apyrimidin-7-amine,5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,5-(2-AMINOETHYL)AMINO-6-FLUORO-3-(1H-PYRROL-2-YL)BENZOCDINDOL-2(1H)-ONE,5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo1,5-apyrimidin-7-amine,5-(4-AMINOCYCLOHEXYL)AMINO-7-(PROPAN-2-YLAMINO)PYRAZOLO1,5-APYRIMIDINE-3-CARBONITRILE,5-5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL-3-{1-(2-CHLOROPHENYL)ETHYLOXY}-2-THIOPHENECARBOXAMIDE,5-chloro-7-(1-methylethyl)aminopyrazolo1,5-apyrimidine-3-carbonitrile,5-hydroxynaphthalene-1-sulfonamide,5-{(2-Amino-9h-Purin-6-Yl)OxyMethyl}-2-Pyrrolidinone,6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo1,2-apyrazin-8-amine,6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-4(5H)-ONE,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO12.3.1.1~3,7~NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE,6-O-Cyclohexylmethyl Guanine,9-amino-5-(2-aminopyrimidin-4-yl)pyrido3',2':4,5pyrrolo1,2-cpyrimidin-4-ol,Double Oxidized Cysteine,Flavopiridol,HYDROXY(OXO)(3-{(2Z)-4-3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYLPYRIMIDIN-2(5H)-YLIDENEAMINO}PHENYL)AMMONIUM,Hymenialdisine,Indirubin-3'-Monoxime,Lysine Nz-Carboxylic Acid,N'-(Pyrrolidino2,1-BIsoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea,N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo1,5-apyrimidin-7-amine,N-(2-METHOXYETHYL)-4-({4-2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YLPYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE,N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,N-(4-{(3S)-3-(dimethylamino)pyrrolidin-1-ylcarbonyl}phenyl)-5-fluoro-4-2-methyl-1-(1-methylethyl)-1H-imidazol-5-ylpyrimidin-2-amine,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,N-3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YLBENZAMIDE,N-4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE,N-4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl-N'-Hydroxyimidoformamide,N-4-(2-Methylimidazo1,2-aPyridin-3-Yl)-2-PyrimidinylAcetamide,N-5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE,N-METHYL-4-{(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYLAMINO}BENZENESULFONAMIDE,N-METHYL-{4-2-(7-OXO-6,7-DIHYDRO-8H-1,3THIAZOLO5,4-EINDOL-8-YLIDENE)HYDRAZINOPHENYL}METHANESULFONAMIDE,N-cyclopropyl-4-pyrazolo1,5-bpyridazin-3-ylpyrimidin-2-amine,N-phenyl-1H-pyrazole-3-carboxamide,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,OLOMOUCINE II,Olomoucine,PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE,Purvalanol,SU9516,Staurosporine,TRIAZOLOPYRIMIDINE,{(2,6-difluorophenyl)carbonylamino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide"		"G=658, A=728"	0.00001	7037.95		"G=356/302, A=350/378"	1	
chr12:58143289	T/C	T	SNV		"CDK4,MIR6759"	"splicesite_5, upstream"	1								50.58			781	"T=0.4942, C=0.5058"		-	6	"NM_000075.3, NR_106817.1"			2.23				"Protein kinase domain,Protein tyrosine kinase"								"ATP binding,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,cell cycle,cell division,chromatin,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytosol,membrane,mitotic cell cycle,nuclear membrane,nucleolus,nucleoplasm,nucleotide binding,nucleus,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,protein binding,protein phosphorylation,regulation of cell cycle,regulation of gene expression,response to drug,signal transduction,transcription factor complex"	"Flavopiridol,Purvalanol"		"T=386, C=395"	0.00001	3719.6		"T=214/172, C=239/156"	1	
chr12:133208979	C/C	T	SNV		POLE	exonic	1								100	p.(=)		1997	"T=0.0, C=1.0"		-	45	NM_006231.3	c.6252A>G	synonymous	-2.14				"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5745022		0.307 (ref)	0.4157	0.2433	0.3573	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		"T=0, C=1997"	0.00001	30423.2		"T=0/0, C=849/1148"	1	
chr12:133219831	C/C	T	SNV		POLE	exonic	1								100	p.(=)		1257	"T=0.0, C=1.0"		-	35	NM_006231.3	c.4530A>G	synonymous	-2.11				"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5744944		0.416 (ref)	0.4306	0.2985	0.4776	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		"T=0, C=1257"	0.00001	19099.6		"T=0/0, C=373/884"	1	
chr12:133236000	T/T	C	SNV		POLE	exonic	1								100	p.(=)		1999	"C=0.0, T=1.0"		-	26	NM_006231.3	c.3156G>A	synonymous	-3				"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5744857		0.416 (ref)	0.4307	0.2985	0.4775	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		"C=0, T=1999"	0.00001	30441.1		"C=0/0, T=905/1094"	1	
chr12:133237632	T/C	T	SNV		POLE	exonic	1								50.08	p.Lys995Glu		1995	"T=0.4992, C=0.5008"		-	25	NM_006231.3	c.2983A>G	missense	1.97	0.25	56	0.014	"DNA polymerase family B,Domain of unknown function (DUF1744)"								"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		"T=996, C=999"	0.00001	9398.83		"T=513/483, C=524/475"	2	
chr12:133240967	G/A	G	SNV		POLE	exonic	1								50.1	p.(=)		998	"G=0.499, A=0.501"		-	22	NM_006231.3	c.2550C>T	synonymous	-1.95				"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5744834		0.01 (ref)	3.00E-04	0.0454	0.0156	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		"G=498, A=500"	0.00001	4674.91		"G=309/189, A=307/193"	1	
chr13:28636084	A/A	G	SNV		FLT3	exonic	1								100	p.(=)		1996	"G=0.0, A=1.0"		-	3	NM_004119.2	c.288C>T	synonymous	0.04				"Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs7338903		0.041 (ref)	0.0105	0.0978	0.0401	YES	"ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity"	"Sorafenib,Sunitinib"		"G=0, A=1996"	0.00001	30413.7		"G=0/0, A=1026/970"	1	
chr13:32906480	A/C	A	SNV		BRCA2	exonic	1								49.25	p.Asn289His		733	"A=0.5075, C=0.4925"		+	10	NM_000059.3	c.865A>C	missense	0.06	0	68	0.4	BRCA2 repeat	rs766173		0.058	0.0368	0.0202	0.0312	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		non-pathogenic	"A=372, C=361"	0.00001	3336.81		"A=213/159, C=182/179"	3	
chr13:32906980	A/G	A	SNV		BRCA2	exonic	1								44.17	p.(=)		1999	"A=0.5583, G=0.4417"		+	10	NM_000059.3	c.1365A>G	synonymous	0.9				BRCA2 repeat	rs1801439		0.058 (ref)	0.0368	0.0198	0.031	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	"A=1116, G=883"	0.00001	7685.15		"A=556/560, G=462/421"	1	
chr13:32910721	T/C	T	SNV		BRCA2	exonic	1								49.5	p.(=)		2000	"T=0.505, C=0.495"		+	11	NM_000059.3	c.2229T>C	synonymous	0.3				BRCA2 repeat	rs1801499		0.058 (ref)	0.037	0.0202	0.0313	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	"T=1010, C=990"	0.00001	9248.23		"T=489/521, C=451/539"	2	
chr13:32911463	A/G	A	SNV		BRCA2	exonic	1								50.97	p.Asn991Asp		516	"A=0.4903, G=0.5097"		+	11	NM_000059.3	c.2971A>G	missense	0.36	1	23	0	BRCA2 repeat	rs1799944		0.062 (ref)	0.0366	0.0386	0.0373	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		non-pathogenic	"A=253, G=263"	0.00001	2507.17		"A=102/151, G=111/152"	2	
chr13:32912008	G/A	G	SNV		BRCA2	exonic	1								47.92	p.(=)		1999	"G=0.5208, A=0.4792"		+	11	NM_000059.3	c.3516G>A	synonymous	-0.21				BRCA2 repeat	rs1799952		0.003 (ref)	0.0041	2.00E-04	0.0028		"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	"G=1041, A=958"	0.00001	8773.42		"G=557/484, A=511/447"	1	
chr13:32912299	T/C	T	SNV		BRCA2	exonic	1								58.32	p.(=)		631	"T=0.4168, C=0.5832"		+	11	NM_000059.3	c.3807T>C	synonymous	0.04				BRCA2 repeat	rs543304		0.179	0.1874	0.1984	0.1911	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	"T=263, C=368"	0.00001	3795.44		"T=113/150, C=156/212"	2	
chr13:32913055	G/G	A	SNV		BRCA2	exonic	1								100	p.(=)		1502	"A=0.0, G=1.0"		+	11	NM_000059.3	c.4563A>G	synonymous	0.6				BRCA2 repeat	rs206075		0.026 (ref)	6.00E-04	0.0704	0.0242	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"			"A=0, G=1502"	0.00001	22825.5		"A=0/0, G=909/593"	1	
chr13:32915005	C/C	G	SNV		BRCA2	exonic	1								100	p.(=)		1729	"G=0.0, C=1.0"		+	11	NM_000059.3	c.6513G>C	synonymous	-1.1				BRCA2 repeat	rs206076		0.026 (ref)	6.00E-04	0.0713	0.0245	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"			"G=0, C=1729"	0.00001	26249.7		"G=0/0, C=955/774"	1	
chr13:32929387	C/C	T	SNV		BRCA2	exonic	1								100	p.Val2466Ala		1435	"T=0.0, C=1.0"		+	14	NM_000059.3	c.7397T>C	missense	1.27	0.58	64	0	BRCA2 repeat	rs169547		0.022 (ref)	6.00E-04	0.0647	0.0223	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	"T=0, C=1435"	0.00001	21827.7		"T=0/0, C=723/712"	1	
chr14:68353886	T/C	T	SNV		RAD51B	exonic	1								50.98	p.Ser241Pro		1999	"T=0.4892, C=0.5108"		+	7	NM_133509.3	c.721T>C	missense	0.14	0.2	74	0.884	Rad51								"ATP binding,DNA binding,DNA recombination,DNA repair,DNA-dependent ATPase activity,blood coagulation,nucleoplasm,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination"			"T=976, C=1019"	0.00001	9495.97		"T=492/484, C=492/527"	1	
chr14:105236741	A/G	A	SNV		AKT1	exonic	1								47.33	p.(=)		1234	"A=0.5267, G=0.4733"		-	14	NM_001014431.1	c.1380T>C	synonymous	-2.54				"PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase"	rs139394285			0	0.0014	5.00E-04		"ATP binding,G-protein coupled receptor signaling pathway,RNA metabolic process,T cell costimulation,activation of pro-apoptotic gene products,activation-induced cell death of T cells,anti-apoptosis,apoptotic process,blood coagulation,carbohydrate metabolic process,carbohydrate transport,cell differentiation,cell proliferation,cellular response to insulin stimulus,cytoplasm,cytosol,endocrine pancreas development,enzyme binding,fibroblast growth factor receptor signaling pathway,identical protein binding,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular signal transduction,kinase activity,mRNA metabolic process,mammary gland epithelial cell differentiation,membrane fraction,microtubule cytoskeleton,multicellular organismal development,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of fatty acid beta-oxidation,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of protein kinase activity,negative regulation of release of cytochrome c from mitochondria,nerve growth factor receptor signaling pathway,nervous system development,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric-oxide synthase regulator activity,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,phosphatidylinositol-3,4,5-trisphosphate binding,phosphatidylinositol-3,4-bisphosphate binding,phosphatidylinositol-mediated signaling,phosphorylation,plasma membrane,platelet activation,positive regulation of anti-apoptosis,positive regulation of blood vessel endothelial cell migration,positive regulation of cell growth,positive regulation of cellular protein metabolic process,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of establishment of protein localization in plasma membrane,positive regulation of fat cell differentiation,positive regulation of glucose import,positive regulation of glucose metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of lipid biosynthetic process,positive regulation of nitric oxide biosynthetic process,positive regulation of nitric-oxide synthase activity,positive regulation of peptidyl-serine phosphorylation,positive regulation of protein phosphorylation,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,protein binding,protein import into nucleus, translocation,protein kinase activity,protein modification process,protein phosphorylation,protein serine/threonine kinase activity,regulation of G1/S transition checkpoint,regulation of cell migration,regulation of glycogen biosynthetic process,regulation of neuron projection development,regulation of nitric-oxide synthase activity,regulation of translation,response to UV-A,response to fluid shear stress,response to heat,signal transduction,transport"	"5-(5-chloro-7H-pyrrolo2,3-dpyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo4,5-cpyridine,Adenosine triphosphate,Arsenic trioxide,Inositol 1,3,4,5-Tetrakisphosphate,N-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl-7H-pyrrolo2,3-dpyrimidin-4-amine"		"A=650, G=584"	0.00001	5303.07		"A=352/298, G=317/267"	1	
chr15:88576185	G/C	G	SNV		NTRK3	exonic	1								53.12	p.(=)		898	"G=0.4688, C=0.5312"		-	14	NM_001012338.2	c.1488C>G	synonymous	-2.01				"Immunoglobulin I-set domain,Immunoglobulin domain,Leucine rich repeat N-terminal domain,Protein kinase domain,Protein tyrosine kinase"	rs2229910		0.322 (ref)	0.3551	0.4048	0.3719	YES	"ATP binding,Golgi membrane,cell differentiation,cellular response to retinoic acid,cochlea development,cytoplasm,integral to plasma membrane,mechanoreceptor differentiation,membrane fraction,modulation by virus of host transcription,multicellular organismal development,negative regulation of astrocyte differentiation,negative regulation of cell death,nervous system development,neuron fate specification,neuron migration,neurotrophin binding,nucleotide binding,plasma membrane,positive regulation of axon extension involved in regeneration,protein autophosphorylation,receptor activity,response to axon injury,response to corticosterone stimulus,response to ethanol,response to stress,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=421, C=477"	0.00001	4553.62		"G=204/217, C=207/270"	2	
chr15:88576232	G/C	G	SNV		NTRK3	exonic	1								46.75	p.Leu481Val		907	"G=0.5325, C=0.4675"		-	14	NM_001012338.2	c.1441C>G	missense	1.12	0	32	0.968	"Immunoglobulin I-set domain,Immunoglobulin domain,Leucine rich repeat N-terminal domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,Golgi membrane,cell differentiation,cellular response to retinoic acid,cochlea development,cytoplasm,integral to plasma membrane,mechanoreceptor differentiation,membrane fraction,modulation by virus of host transcription,multicellular organismal development,negative regulation of astrocyte differentiation,negative regulation of cell death,nervous system development,neuron fate specification,neuron migration,neurotrophin binding,nucleotide binding,plasma membrane,positive regulation of axon extension involved in regeneration,protein autophosphorylation,receptor activity,response to axon injury,response to corticosterone stimulus,response to ethanol,response to stress,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=483, C=424"	0.00001	3816.89		"G=208/275, C=201/223"	1	
chr15:89837191	A/G	A	SNV		FANCI	exonic	1								46.38	p.Met807Val		1643	"A=0.5362, G=0.4638"		+	23	NM_001113378.1	c.2419A>G	missense	-0.2	0.04	21	0.023									"DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding"			"A=881, G=762"	0.00001	6806.28		"A=442/439, G=396/366"	1	
chr15:89838236	A/A	G	SNV		FANCI	exonic	1								100	p.(=)		1982	"G=0.0, A=1.0"		+	24	NM_001113378.1	c.2547G>A	synonymous	0.3					rs7183618		0.027 (ref)	0.0535	0.0087	0.0399	YES	"DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding"			"G=0, A=1982"	0.00001	30051.7		"G=0/0, A=1054/928"	2	
chr16:2120544	T/C	T	SNV		TSC2	exonic	1								47.69	p.Tyr602His		757	"T=0.5231, C=0.4769"		+	17	NM_000548.3	c.1804T>C	missense	2.1	0.06	83	0.999	"Rap/ran-GAP,Tuberin"								"14-3-3 protein binding,GTPase activator activity,Golgi apparatus,TSC1-TSC2 complex,acute-phase response,caveola,cell cycle arrest,cell projection organization,cytoplasm,cytoskeletal part,cytosol,dendrite,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular,membrane,membrane fraction,microsome,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,vesicle-mediated transport"			"T=396, C=361"	0.00001	3305.51		"T=226/170, C=206/155"	1	
chr16:2124258	G/A	G	SNV		TSC2	exonic	1								44.15	p.Val805Ile		650	"G=0.5585, A=0.4415"		+	22	NM_000548.3	c.2413G>A	missense	2.5	0.66	29	0.994	"Rap/ran-GAP,Tuberin"								"14-3-3 protein binding,GTPase activator activity,Golgi apparatus,TSC1-TSC2 complex,acute-phase response,caveola,cell cycle arrest,cell projection organization,cytoplasm,cytoskeletal part,cytosol,dendrite,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular,membrane,membrane fraction,microsome,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,vesicle-mediated transport"			"G=363, A=287"	0.00001	2477.22		"G=160/203, A=125/162"	1	
chr16:2138269	T/C	T	SNV		"PKD1,TSC2"	"exonic, downstream"	1								49.05	p.(=)		891	"T=0.5095, C=0.4905"		"+, -"	41	"NM_000548.3, NM_001009944.2"	c.5202T>C	synonymous	0.34				"Rap/ran-GAP,Tuberin"	"rs137854091,rs1748"		0.258	0.1781	0.3656	0.3325	YES	"14-3-3 protein binding,GTPase activator activity,Golgi apparatus,JAK-STAT cascade,TSC1-TSC2 complex,acute-phase response,anatomical structure morphogenesis,basolateral plasma membrane,blood vessel development,branching morphogenesis of a tube,calcium ion transport,calcium-independent cell-matrix adhesion,cartilage condensation,cation channel activity,caveola,cell cycle arrest,cell projection organization,cell-matrix adhesion,cilium,cytoplasm,cytoskeletal part,cytosol,dendrite,detection of mechanical stimulus,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,homophilic cell adhesion,in utero embryonic development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,integral to plasma membrane,intracellular,membrane,membrane fraction,microsome,motile primary cilium,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,neuropeptide signaling pathway,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,plasma membrane,polycystin complex,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein domain specific binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein kinase binding,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,sugar binding,vesicle-mediated transport"		untested	"T=454, C=437"	0.00001	4035.67		"T=205/249, C=192/245"	1	
chr16:3639139	G/G	A	SNV		SLX4	exonic	1								100	p.(=)		1289	"A=0.0, G=1.0"		-	12	NM_032444.2	c.4500T>C	synonymous	0.83				BTB/POZ domain	rs3810812		0.306 (ref)	0.4923	0.1406	0.3734	YES	"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			"A=0, G=1289"	0.00001	19569.3		"A=0/0, G=565/724"	1	
chr16:3640274	G/A	G	SNV		SLX4	exonic	1								46.1	p.Pro1122Leu		1998	"G=0.539, A=0.461"		-	12	NM_032444.2	c.3365C>T	missense	-0.33	1	98	0.003	BTB/POZ domain	rs714181		0.198 (ref)	0.0841	0.4613	0.2116	YES	"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			"G=1077, A=921"	0.00001	8235.43		"G=538/539, A=441/480"	2	
chr16:3644535	G/A	G	SNV		SLX4	exonic	1								46.56	p.(=)		683	"G=0.5344, A=0.4656"		-	10	NM_032444.2	c.2079C>T	synonymous	0.09				BTB/POZ domain	rs150206155		0.001 (ref)	0	7.00E-04	2.00E-04		"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			"G=365, A=318"	0.00001	2835.56		"G=189/176, A=157/161"	2	
chr16:3656482	C/T	C	SNV		SLX4	exonic	1								54.21	p.(=)		784	"C=0.4579, T=0.5421"		-	3	NM_032444.2	c.753G>A	synonymous	-3.47				BTB/POZ domain	rs8061528		0.25 (ref)	0.203	0.2501	0.2189	YES	"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			"C=359, T=425"	0.00001	4181.14		"C=186/173, T=208/217"	4	
chr16:3781466	G/A	G	SNV		CREBBP	exonic	1								49.64	p.(=)		1507	"G=0.5036, A=0.4964"		-	30	NM_004380.2	c.4899C>T	synonymous	0.15				"Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger"								"MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding"	"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE"		"G=759, A=748"	0.00001	6969.19		"G=346/413, A=359/389"	1	
chr16:3808052	TAAAAAA/T	TAAAAAA	INDEL		CREBBP	splicesite_5	6								16.29			4609	"TAAAAAA=0.8371, T=0.1629"		-	18	NM_004380.2			"0.07,-1.3,-1.3,0.26,0.08,0.96,0.96"				"Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger"	rs75459669			0.2037	0.4503	0.2877		"MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding"	"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE"		"TAAAAAA=3858, T=751"	0.03162	15				
chr16:3820854	A/G	A	SNV		CREBBP	exonic	1								50.75	p.Met866Thr		1998	"A=0.4925, G=0.5075"		-	14	NM_004380.2	c.2597T>C	missense	2.29	0.8	81	0.015	"Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger"								"MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding"	"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE"		"A=984, G=1014"	0.00001	9618.3		"A=487/497, G=507/507"	1	
chr16:3828820	T/C	T	SNV		CREBBP	splicesite_5	1								49.39			1142	"T=0.5061, C=0.4939"		-	9	NM_004380.2			2.04				"Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger"								"MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding"	"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE"		"T=578, C=564"	0.00001	5241.17		"T=415/163, C=460/104"	1	
chr16:3900763	G/A	G	SNV		CREBBP	exonic	1								47.24	p.(=)		1793	"G=0.5276, A=0.4724"		-	2	NM_004380.2	c.333C>T	synonymous	0.4				"Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger"	rs150229705		0.001 (ref)	0	0.0073	0.0025		"MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding"	"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE"		"G=946, A=847"	0.00001	7682.61		"G=529/417, A=457/390"	1	
chr16:89836323	T/T	C	SNV		FANCA	exonic	1								100	p.Gly809Asp		1993	"C=0.0, T=1.0"		-	26	NM_000135.2	c.2426G>A	missense	-0.2	0.78	94	0	Fanconi anaemia group A protein	rs7195066		0.384 (ref)	0.3142	0.3414	0.4307	YES	"DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation"			"C=0, T=1993"	0.00001	30232.6		"C=0/0, T=993/1000"	2	
chr16:89849480	C/T	C	SNV		FANCA	exonic	1								49.37	p.Gly501Ser		1999	"C=0.5063, T=0.4937"		-	16	NM_000135.2	c.1501G>A	missense	-1.69	1	56	0	Fanconi anaemia group A protein	rs2239359		0.393 (ref)	0.381	0.3196	0.4823	YES	"DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation"			"C=1012, T=987"	0.00001	9205.56		"C=472/540, T=486/501"	2	
chr16:89858926	ACT/A	ACT	INDEL		FANCA	exonic	2	Deleterious	Loss-of-function						47.67	p.Glu345fs		1972	"ACT=0.5233, A=0.4767"		-	12	NM_000135.2	c.1034_1035delAG	frameshiftDeletion	"2.21,-0.84,2.21"				Fanconi anaemia group A protein								"DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation"			"ACT=1032, A=940"	0.00001	8554.73		"ACT=482/550, A=452/488"	1	
chr16:89866043	C/C	T	SNV		FANCA	exonic	1								100	p.Thr266Ala		1892	"T=0.0, C=1.0"		-	9	NM_000135.2	c.796A>G	missense	0.38	1	58	0	Fanconi anaemia group A protein	rs7190823		0.343 (ref)	0.3937	0.2743	0.494	YES	"DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation"			"T=0, C=1892"	0.00001	28724.5		"T=0/0, C=836/1056"	1	
chr17:7579472	G/C	G	SNV		TP53	exonic	1								46.2	p.Pro72Arg		1998	"G=0.538, C=0.462"		-	4	NM_000546.5	c.215C>G	missense	1.36	0.6	103	0.083	"P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif"	rs1042522		0.398 (ref)	0.2548	0.4051	0.37	YES	"ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding"	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	non-pathogenic	"G=1075, C=923"	0.00001	8264.97		"G=489/586, C=417/506"	6	
chr17:29508775	G/A	G	SNV		NF1	exonic	1								52.88	p.(=)		1354	"G=0.4712, A=0.5288"		+	7	NM_001042492.2	c.702G>A	synonymous	-3.81				GTPase-activator protein for Ras-like GTPase	rs1801052		0.45 (ref)	0.2899	0.3098	0.4256	YES	"MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing"			"G=638, A=716"	0.00001	6959.69		"G=405/233, A=429/287"	1	
chr17:29553485	G/A	G	SNV		NF1	exonic	1								50.63	p.(=)		1995	"G=0.4937, A=0.5063"		+	18	NM_001042492.2	c.2034G>A	synonymous	-2.42				GTPase-activator protein for Ras-like GTPase	rs2285892		0.471 (ref)	0.2891	0.3352	0.4163	YES	"MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing"			"G=985, A=1010"	0.00001	9557.83		"G=430/555, A=449/561"	1	
chr17:29556177	G/A	G	SNV		NF1	exonic	1								50.6	p.(=)		2000	"G=0.494, A=0.506"		+	21	NM_001042492.2	c.2544G>A	synonymous	0.68				GTPase-activator protein for Ras-like GTPase	rs17883704		0.023 (ref)	6.00E-04	0.0749	0.0258	YES	"MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing"			"G=988, A=1012"	0.00001	9574.03		"G=501/487, A=524/488"	5	
chr17:29667619	CA/C	CA	INDEL		NF1	exonic	1								51.46	p.Asn2341fs		1990	"CA=0.4854, C=0.5146"		+	47	NM_001042492.2	c.7022delA	frameshiftDeletion	"2.89,2.33"				GTPase-activator protein for Ras-like GTPase								"MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing"			"CA=966, C=1024"	0.00001	8804.18		"CA=475/491, C=533/491"	4	
chr17:40475060	CCTT/C	CCTT	INDEL		STAT3	exonic	3								49.72	p.Glu616del		531	"CCTT=0.5028, C=0.4972"		-	20	NM_139276.2	c.1847_1849delAAG	nonframeshiftDeletion	"2.75,2.75,0.45,2.22"				"SH2 domain,STAT protein"								"CCR5 chemokine receptor binding,DNA binding,JAK-STAT cascade,JAK-STAT cascade involved in growth hormone signaling pathway,acute-phase response,astrocyte differentiation,calcium ion binding,cellular component movement,cellular response to hormone stimulus,cytokine-mediated signaling pathway,cytoplasm,cytosol,eating behavior,eye photoreceptor cell differentiation,glucocorticoid receptor binding,glucose homeostasis,growth hormone receptor signaling pathway,interleukin-6-mediated signaling pathway,interspecies interaction between organisms,negative regulation of transcription from RNA polymerase II promoter,nerve growth factor receptor signaling pathway,nervous system development,non-membrane spanning protein tyrosine kinase activity,nucleolus,nucleoplasm,nucleus,plasma membrane,positive regulation of Notch signaling pathway,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein dimerization activity,protein import into nucleus,protein kinase binding,radial glial cell differentiation,regulation of multicellular organism growth,regulation of transcription from RNA polymerase II promoter,regulation of transcription, DNA-dependent,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to ethanol,response to organic cyclic compound,response to peptide hormone stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,sexual reproduction,signal transducer activity,signal transduction,temperature homeostasis,transcription factor binding,transcription regulatory region DNA binding"			"CCTT=267, C=264"	0.00001	2452.26		"CCTT=152/115, C=145/119"	2	
chr17:41223094	T/C	T	SNV		BRCA1	exonic	1								52.6	p.Ser1634Gly		2000	"T=0.474, C=0.526"		-	16	NM_007300.3	c.4900A>G	missense	0.13	0.03	56	0.58	"BRCA1 C Terminus (BRCT) domain,Zinc finger"	rs1799966		0.327	0.3266	0.2426	0.2982	YES	"BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding"		non-pathogenic	"T=948, C=1052"	0.00001	10198.5		"T=491/457, C=579/473"	1	
chr17:41244000	T/C	T	SNV		BRCA1	exonic	1								52.2	p.Lys1183Arg		2000	"T=0.478, C=0.522"		-	10	NM_007300.3	c.3548A>G	missense	-0.44	1	26	0	"BRCA1 C Terminus (BRCT) domain,Zinc finger"	"rs16942,rs80357956"		0.324 (ref)	0.3244	0.2383	0.2952	YES	"BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding"		non-pathogenic	"T=956, C=1044"	0.00001	10070.4		"T=427/529, C=548/496"	3	
chr17:41244936	A/A	G	SNV		BRCA1	exonic	1								100	p.Pro871Leu		1985	"G=0.0, A=1.0"		-	10	NM_007300.3	c.2612C>T	missense	0.94	1	98	0	"BRCA1 C Terminus (BRCT) domain,Zinc finger"	"rs799917,rs80357962"		0.483	0.3359	0.2	0.4932	YES	"BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding"		non-pathogenic	"G=0, A=1985"	0.00001	30032.8		"G=0/0, A=964/1021"	2	
chr17:41245090	T/C	T	SNV		BRCA1	exonic	1								52.38	p.Lys820Glu		378	"T=0.4762, C=0.5238"		-	10	NM_007300.3	c.2458A>G	missense	0.05	0.12	56	0.008	"BRCA1 C Terminus (BRCT) domain,Zinc finger"	"rs56082113,rs80357669"		0.014 (ref)	0	0.0297	0.0101	YES	"BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding"		non-pathogenic	"T=180, C=198"	0.00001	1894.66		"T=93/87, C=102/96"	3	
chr17:41245466	G/A	G	SNV		BRCA1	exonic	1								45.72	p.(=)		1999	"G=0.5428, A=0.4572"		-	10	NM_007300.3	c.2082C>T	synonymous	-0.08				"BRCA1 C Terminus (BRCT) domain,Zinc finger"	rs1799949		0.324 (ref)	0.3244	0.2396	0.2957	YES	"BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding"		untested	"G=1085, A=914"	0.00001	8125.9		"G=773/312, A=618/296"	1	
chr17:41246245	C/A	C	SNV		BRCA1	exonic	1								47.35	p.Asp435Tyr		1998	"C=0.5265, A=0.4735"		-	10	NM_007300.3	c.1303G>T	missense	0.28	0	160	1	"BRCA1 C Terminus (BRCT) domain,Zinc finger"								"BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding"			"C=1052, A=946"	0.00001	8602.38		"C=493/559, A=467/479"	1	
chr17:56435492	G/T	G	SNV		RNF43	exonic	1								46.88	p.His549Asn		1041	"G=0.5312, T=0.4688"		-	9	NM_017763.4	c.1645C>A	missense	2.52	0	68	0.997	Zinc finger								"endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding"			"G=553, T=488"	0.00001	4377.83		"G=282/271, T=249/239"	2	
chr19:1218493	AG/A	AG	INDEL		STK11	exonic	1	Deleterious	Loss-of-function						49.22	p.Met125fs		1995	"AG=0.5078, A=0.4922"		+	2	NM_000455.4	c.369delG	frameshiftDeletion	"1.51,0.23"				"Protein kinase domain,Protein tyrosine kinase"	rs140112347		0.006					"ATP binding,Golgi localization,LRR domain binding,anoikis,autophagy,canonical Wnt receptor signaling pathway,cell cycle,cell cycle arrest,cytoplasm,cytosol,energy reserve metabolic process,establishment of cell polarity,glucose homeostasis,insulin receptor signaling pathway,magnesium ion binding,membrane,mitochondrion,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of epithelial cell proliferation involved in prostate gland development,nucleotide binding,nucleus,p53 binding,positive regulation of axonogenesis,positive regulation of gluconeogenesis,positive regulation of protein phosphorylation,positive regulation of transforming growth factor beta receptor signaling pathway,protein autophosphorylation,protein binding,protein complex,protein heterooligomerization,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of Wnt receptor signaling pathway,regulation of cell growth,regulation of fatty acid biosynthetic process,regulation of fatty acid oxidation,regulation of protein kinase B signaling cascade,response to DNA damage stimulus,response to glucagon stimulus,response to ionizing radiation,response to lipid,signal transduction by p53 class mediator resulting in induction of apoptosis,tissue homeostasis,vasculature development"			"AG=1013, A=982"	0.00001	8997.88		"AG=516/497, A=520/462"	1	
chr19:1221293	C/T	C	SNV		STK11	exonic	1								52.02	p.(=)		1513	"C=0.4798, T=0.5202"		+	6	NM_000455.4	c.816C>T	synonymous	0.99				"Protein kinase domain,Protein tyrosine kinase"	rs9282859		0.019 (ref)	7.00E-04	0.0744	0.0245	YES	"ATP binding,Golgi localization,LRR domain binding,anoikis,autophagy,canonical Wnt receptor signaling pathway,cell cycle,cell cycle arrest,cytoplasm,cytosol,energy reserve metabolic process,establishment of cell polarity,glucose homeostasis,insulin receptor signaling pathway,magnesium ion binding,membrane,mitochondrion,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of epithelial cell proliferation involved in prostate gland development,nucleotide binding,nucleus,p53 binding,positive regulation of axonogenesis,positive regulation of gluconeogenesis,positive regulation of protein phosphorylation,positive regulation of transforming growth factor beta receptor signaling pathway,protein autophosphorylation,protein binding,protein complex,protein heterooligomerization,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of Wnt receptor signaling pathway,regulation of cell growth,regulation of fatty acid biosynthetic process,regulation of fatty acid oxidation,regulation of protein kinase B signaling cascade,response to DNA damage stimulus,response to glucagon stimulus,response to ionizing radiation,response to lipid,signal transduction by p53 class mediator resulting in induction of apoptosis,tissue homeostasis,vasculature development"			"C=726, T=787"	0.00001	7574.06		"C=146/580, T=184/603"	1	
chr19:4117528	G/A	G	SNV		MAP2K2	exonic	1								56.67	p.(=)		30	"G=0.4333, A=0.5667"		-	2	NM_030662.3	c.192C>T	synonymous	-0.47				"Protein kinase domain,Protein tyrosine kinase"	rs8157		0.049 (ref)	0.0599	0.0695	0.0631	YES	"ATP binding,ERK1 and ERK2 cascade,MAP kinase kinase activity,MAPKKK cascade,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,Ras protein signal transduction,Toll signaling pathway,activation of MAPK activity,activation of MAPKK activity,axon guidance,cell cortex,cytosol,epidermal growth factor receptor signaling pathway,extracellular region,innate immune response,insulin receptor signaling pathway,nerve growth factor receptor signaling pathway,nucleotide binding,positive regulation of cell motility,protein binding,protein complex scaffold,protein phosphorylation,protein serine/threonine kinase activity,protein tyrosine kinase activity,small GTPase mediated signal transduction,soluble fraction,stress-activated MAPK cascade,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,toll-like receptor signaling pathway"			"G=13, A=17"	0.00001	166.079		"G=5/8, A=6/11"	1	
chr19:15271771	G/A	G	SNV		NOTCH3	exonic	1								52.34	p.Ala2223Val		1985	"G=0.4766, A=0.5234"		-	33	NM_000435.2	c.6668C>T	missense	0.08	0.18	64	0.001	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1044009		0.368 (ref)	0.1987	0.397	0.2651	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"G=946, A=1039"	0.00001	10030.9		"G=380/566, A=424/615"	1	
chr19:15278057	G/G	A	SNV		NOTCH3	splicesite_3	1								100			850	"A=0.0, G=1.0"		-	29	NM_000435.2			0.62				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1548555		0.133 (ref)	0.1034	0.0236	0.0763	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"A=0, G=850"	0.00001	12852.2		"A=0/0, G=379/471"	2	
chr19:15285008	C/T	C	SNV		NOTCH3	exonic	1								6.92	p.Ser1536Asn		954	"C=0.9308, T=0.0692"		-	25	NM_000435.2	c.4607G>A	missense	2.23	0.03	46	0.929	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"								"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"C=888, T=66"	0.00001	96.0431		"C=537/351, T=34/32"	1	
chr19:15285052	C/C	T	SNV		NOTCH3	exonic	1								100	p.(=)		866	"T=0.0, C=1.0"		-	25	NM_000435.2	c.4563A>G	synonymous	-1.43				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1044006		0.133 (ref)	0.1002	0.0223	0.0739	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"T=0, C=866"	0.00001	13141.3		"T=0/0, C=400/466"	1	
chr19:15289874	C/T	C	SNV		"MIR6795,NOTCH3"	"exonic, downstream"	1								47.9	p.Gly1227Asp		2000	"C=0.521, T=0.479"		-	22	"NM_000435.2, NR_106853.1"	c.3680G>A	missense	1.72	0.16	94	0.991	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"								"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"C=1042, T=958"	0.00001	8763.89		"C=512/530, T=486/472"	2	
chr19:15289954	CA/C	CA	INDEL		"MIR6795,NOTCH3"	"exonic, downstream"	1	Deleterious	Loss-of-function						51.32	p.Leu1200fs		721	"CA=0.4868, C=0.5132"		-	22	"NM_000435.2, NR_106853.1"	c.3599delT	frameshiftDeletion	"0.58,1.41"				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"								"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"CA=351, C=370"	0.00001	3390.36		"CA=188/163, C=207/163"	3	
chr19:15290007	C/T	C	SNV		"MIR6795,NOTCH3"	"exonic, downstream"	1								56.87	p.Val1183Met		1463	"C=0.4313, T=0.5687"		-	22	"NM_000435.2, NR_106853.1"	c.3547G>A	missense	1.72	0.02	21	0.698	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs10408676		0.067 (ref)	0.0078	0.2419	0.0871	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"C=631, T=832"	0.00001	8432.92		"C=330/301, T=402/430"	1	
chr19:15291576	C/G	C	SNV		NOTCH3	exonic	1								48.74	p.Ala1020Pro		1988	"C=0.5126, G=0.4874"		-	19	NM_000435.2	c.3058G>C	missense	0.57	0.04	27	0.027	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs35769976		0.084 (ref)	0.0142	0.2941	0.1089	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"		unknown	"C=1019, G=969"	0.00001	8909.11		"C=483/536, G=449/520"	4	
chr19:15292437	T/C	T	SNV		NOTCH3	exonic	1								51.13	p.(=)		1418	"T=0.4887, C=0.5113"		-	17	NM_000435.2	c.2742A>G	synonymous	-4.38				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1043997		0.233 (ref)	0.1299	0.3636	0.2095	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"T=693, C=725"	0.00001	6881.12		"T=396/297, C=410/315"	1	
chr19:15302844	C/C	T	SNV		NOTCH3	exonic	1								100	p.(=)		1753	"T=0.0, C=1.0"		-	4	NM_000435.2	c.606A>G	synonymous	-2.59				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1043994		0.144 (ref)	0.1224	0.0878	0.1107	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"T=0, C=1753"	0.00001	26675		"T=0/0, C=851/902"	1	
chr19:15303225	G/A	G	SNV		NOTCH3	exonic	1								49.75	p.(=)		2000	"G=0.5025, A=0.4975"		-	3	NM_000435.2	c.303C>T	synonymous	-0.55				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs3815188		0.238 (ref)	0.147	0.2544	0.1834	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			"G=1005, A=995"	0.00001	9324.12		"G=522/483, A=564/431"	2	
chr20:36030939	C/C	G	SNV		SRC	exonic	1								100	p.(=)		1993	"G=0.0, C=1.0"		+	12	NM_198291.2	c.1218G>C	synonymous	-2.02				"Protein kinase domain,Protein tyrosine kinase,SH2 domain,SH3 domain,Variant SH3 domain"	rs1885257		0.012 (ref)					"ATP binding,Ras protein signal transduction,SH2 domain binding,SH3/SH2 adaptor activity,T cell costimulation,axon guidance,blood coagulation,bone resorption,branching involved in mammary gland duct morphogenesis,caveola,cell adhesion,cell cycle,cell junction assembly,cellular membrane organization,cytoplasm,cytoskeleton,cytosol,ephrin receptor binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,forebrain development,heme binding,integrin binding,interspecies interaction between organisms,intracellular protein kinase cascade,ion channel binding,kinase activity,leukocyte migration,mitochondrial inner membrane,mitochondrion,nerve growth factor receptor signaling pathway,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,oogenesis,peptidyl-tyrosine phosphorylation,phosphorylation,plasma membrane,platelet activation,positive regulation of integrin activation,protein binding,protein kinase activity,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of bone resorption,regulation of intracellular estrogen receptor signaling pathway,regulation of vascular permeability,response to interleukin-1,signal complex assembly,signal transduction,uterus development"	"(2E)-N-{4-(3-bromophenyl)aminoquinazolin-6-yl}-4-(dimethylamino)but-2-enamide,1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo3,4-dpyrimidin-4-amine,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-naphthalen-1-ylurea,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-phenylurea,1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo3,4-dpyrimidin-4-amine,1-cyclopentyl-3-(1H-pyrrolo2,3-bpyridin-5-yl)-1H-pyrazolo3,4-dpyrimidin-4-amine,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,3-4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-3-YLPHENOL,4-(4-METHYL-1-PIPERAZINYL)METHYL-N-3-4-(3-PYRIDINYL)-2-PYRIMIDINYLAMINOPHENYL-BENZAMIDE,4-({4-(5-cyclopropyl-1H-pyrazol-3-yl)aminoquinazolin-2-yl}amino)phenylacetonitrile,Citric Acid,DPI59,Dasatinib,ISO24,Malonic acid,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,N6-Benzyl Adenosine-5'-Diphosphate,Oxalic Acid,PAS219,PASBN,Phenylphosphate,Phosphonotyrosine,Purvalanol A,RU78191,RU78262,RU78299,RU78300,RU78783,RU79072,RU79073,RU79256,RU81843,RU82129,RU82197,RU82209,RU83876,RU84687,RU85053,RU85493,RU90395"		"G=0, C=1993"	0.00001	30303.6		"G=0/0, C=946/1047"	2	
chr22:30060990	AC/A	AC	INDEL		NF2	exonic	1	Deleterious	Loss-of-function						46.12	p.Pro275fs		915	"AC=0.5388, A=0.4612"		+	9	NM_000268.3	c.824delC	frameshiftDeletion	"0.15,2.76"				"Ezrin/radixin/moesin family,FERM central domain"								"Schwann cell proliferation,actin cytoskeleton organization,adherens junction,cell-cell junction organization,cleavage furrow,cytoplasm,cytoskeletal protein binding,cytoskeleton,early endosome,ectoderm development,extrinsic to membrane,filopodium membrane,lamellipodium,lens fiber cell differentiation,mesoderm formation,negative regulation of DNA replication,negative regulation of JAK-STAT cascade,negative regulation of MAPKKK cascade,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of cell-cell adhesion,negative regulation of cell-matrix adhesion,negative regulation of protein kinase activity,negative regulation of tyrosine phosphorylation of Stat3 protein,negative regulation of tyrosine phosphorylation of Stat5 protein,nucleolus,nucleus,odontogenesis of dentin-containing tooth,perinuclear region of cytoplasm,plasma membrane,positive regulation of stress fiber assembly,protein binding,regulation of hippo signaling cascade,ruffle membrane"			"AC=493, A=422"	0.00001	3717.53		"AC=257/236, A=226/196"	2	
chrX:76763988	C/T	C	SNV		ATRX	exonic	1								45.67	p.(=)		1984	"C=0.5433, T=0.4567"		-	35	NM_000489.4	c.7320G>A	synonymous	1.13				"Helicase conserved C-terminal domain,SNF2 family N-terminal domain"	rs149242238			0	3.00E-04	1.00E-04		"ATP binding,DNA binding,DNA helicase activity,DNA methylation,DNA recombination,DNA repair,chromatin binding,chromo shadow domain binding,forebrain development,helicase activity,hydrolase activity,metal ion binding,nuclear chromosome,nuclear heterochromatin,nucleotide binding,nucleus,protein binding,regulation of transcription, DNA-dependent,zinc ion binding"			"C=1078, T=906"	0.00001	7985.9		"C=547/531, T=460/446"	1	
chrX:76937963	G/C	G	SNV		ATRX	exonic	1								54.1	p.Gln929Glu		1998	"G=0.459, C=0.541"		-	9	NM_000489.4	c.2785C>G	missense	0.61	1	29	0	"Helicase conserved C-terminal domain,SNF2 family N-terminal domain"	rs3088074		0.49 (ref)	0.306	0.1369	0.4917	YES	"ATP binding,DNA binding,DNA helicase activity,DNA methylation,DNA recombination,DNA repair,chromatin binding,chromo shadow domain binding,forebrain development,helicase activity,hydrolase activity,metal ion binding,nuclear chromosome,nuclear heterochromatin,nucleotide binding,nucleus,protein binding,regulation of transcription, DNA-dependent,zinc ion binding"			"G=917, C=1081"	0.00001	10660.8		"G=416/501, C=559/522"	1	